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Abstract 
Studies in Polyketide Total Synthesis 
Stephen Ho 
 
This dissertation will describe the development of a practical and scalable crotylation 
reaction with application toward the total syntheses of two polyketide-derived natural 
products: Zincophorin and Dictyostatin. 
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a The work described in this chapter was conducted in conjunction with Dr. Hyunwoo Kim, a postdoctoral 
associate in the lab. This is noted accordingly where applicable. 
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I. Introduction 
The Leighton Group has had a sustained interest in polyketide-derived natural products. 
We have been inspired by their structural complexity and bioactivity, and have sought to 
understand the underlying chemistry needed to achieve their total syntheses. Our targets 
are chosen not as endpoints but with the recognition that supply and performance issues 
are limiting their therapeutic value. Because solutions to these problems could positively 
impact human health, we undertake synthesis projects with two goals in mind: (a) mean-
ingful quantities of the natural product and (b) the ability to rapidly evaluate analog struc-
tures with improved function. 
Figure 1.1: Polyketide Synthesis Projects (2008 – 2013) 
 
 
Polyketide total synthesis can be systematically performed because of their modular bio-
synthetic origins,1,2 allowing structural motifs shared by the whole family to be targeted. 
Thus, a single project can outline synthesis strategies extending well beyond one target. 
For example, because polyketides are repeating arrays of acetate and/or propionate units, 
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This reaction sets vicinal stereocenters and affords a terminal olefin for further function-
alization; subsequent oxidative cleavage can afford a second aldehyde, which can in turn 
be crotylated or otherwise react (Scheme 1.1). Thus, the overall sequence of crotylation 
/functionalization/crotylation can well be adopted for the synthesis of polyketide targets. 
In Chapter 1, I will present (a) our contributions to the crotylation reaction,5 (b) a 
demonstration of its utility in a short synthesis of Zincophorin, a typical polypropionate 
natural product.6 
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II. Motivation and Initial Results 
In 2010, our group was in the midst of a synthesis of Zincophorin, a typical polypropio-
nate natural product. We were confronted with the crotylation of two aldehydes in prepar-
ing the C16-C26 fragment (Scheme 1.2A), and we wanted to use crotylsilanes 1 and 27 
because they were developed in-house (ca. 2003) and possessed significant practical ad-
vantages over the Brown ipc-reagent, the dominant crotylation method at the time. In par-
ticular, (a) the crotylsilanes are storable crystalline solidsb and (b) the reactions can be 
run at ambient temperatures ("dump and stir"). However, at that time, the substrate scope 
was limited to unhindered, aliphatic aldehydes. Thus, while (S,S)-1 could crotylate pro-
pionaldehyde, (S,S)-2 was completely unreactive with the unsaturated aldehyde shown in 
Scheme 1.2B. 
Scheme 1.2: Crotylation Reactions in Zincophorin 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  




















(S,S)-1: R1 = Me, R2 = H
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To address the poor reactivity, we conceived of the idea of adding an additional Lewis or 
Bronsted acid,c which could be anticipated to bind to the diamine backbone and thereby 
increase the Lewis acidity of silicon. Dr. Hyunwoo Kim conducted a screen of acidsd and 
discovered that the addition of scandium triflate resulted in tremendous rate acceleration. 
Crotylation products could now be readily obtained in high yield and excellent diastereo- 
and enantioselectivity (Scheme 1.2B). 
 With these initial results in hand, we sought to (a) establish the scope of the reac-
tion and (b) simplify the preparation of the reagents to facilitate commercialization. 
III. Crotylation Substrate Scope 
Achiral Aldehydes: Dr. Kim surveyed three representative achiral aldehydes and observed 
that 5 mol% scandium triflate was sufficient to catalyze complete conversion of starting 
material, in less than 1h at ambient temperature. Moreover, an acidic workup allowed re-
covery of the diamine controller in 95% yield. The yields and enantioselectivities were 
uniformly high. Side-by side comparisons for these aldehydes are provided in Figure 1.2. 
 
Figure 1.2: Crotylation of Standard Achiral Aldehydes 
We also discovered that β-silyl unsaturated aldehydes (prepared via alkyne silylformyla-
tion) could be effectively crotylated, with substantial flexibility in the identity of the sili-
con substituents (Scheme 1.3A). The resulting adducts are versatile intermediates because 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
c The Hall Group had previously shown that either Lewis23 or Bronsted11,24,25 acids could catalyze the reac-
tion between allylboronates and aldehydes/ketones. 
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the vinylsilane can be exploited in a variety of functionalization reaction, as depicted in 
Scheme 1.3B.8 
Scheme 1.3: (a) Crotylation of β-Silyl Aldehydes; (b) Vinylsilane Functionalization 
 
 
Chiral Aldehydes: We also examined reactions of chiral aldehydes to establish the extent 
to which the chiral diamine controller could override intrinsic diastereofacial biases. With 
Roche ester-derived aldehydes, which bear an α stereocenter, all stereochemical permuta-
tions are possible with excellent reagent-control (Figure 1.3). Further, our silane platform 
displays higher selectivities than both the Roush9,10 and Hall11 boronate protocols. 
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Aldehydes with α and β stereocenters have historically been more difficult substrates to 
crotylate with high reagent control because there are 8 stereochemical outcomes and one 
has to worry about (a) the effects of both stereocenters and (b) the size and electronics of 
the hydroxyl protecting group. However, with our diamine controller, we can successful-
ly access 6/8 products (A-C, E-G), provided a judicious choice in protecting groups (Fig-
ure 1.4). For comparison, the Brown ipc reagent can deliver 4/8 adducts (A, C, F, G).5 
 
Figure 1.4: Crotylation of α,β-Substituted Aldehydes (5 mol% Sc(OTf)3, 4h) 
The anti-anti configurations (adducts D and H) remain elusive and despite creative work 
from the Roush Group,12–14 this remains an unsolved problem. The difficulty can be un-
derstood by analyzing the chair-like Zimmerman-Traxler transition states in which syn-
pentane interactions are assumed to be energetically prohibitive. 
In the (anti-Felkin) pathway toward the anti-anti product, a non-hydrogen substit-
uent is forced over the six reacting ring atoms (Scheme 1.4 Top). This steric interaction 
evidently overrides the bias imparted from the chiral controller, and the reaction proceeds 
through the Felkin pathway (Scheme 1.4 Bottom). Although a screen of protecting groups 
revealed that smaller ones result in better diastereoselectivity (compare PMB vs. TBS in 
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Scheme 1.4: Analysis of Competing Transition States 
 
 
In screening protecting groups, PMB protected hydroxyls were observed to partially (5-
20%) deprotect during the reaction to afford 1,3-diols (Scheme 1.5). This deprotection 
only occurs with hydroxyl groups at the β position and is thus believed to take place after 
the crotylation event, when the chlorosilane can act intramolecularly in a 6-membered 
ring to activate the pendant group. A similar deprotection occurs with acetal protecting 
groups, while esters and silyl ethers remain intact. Although this phenomenon can be ex-
ploited as a 1-pot crotylation / deprotection sequence, it does somewhat limit the compat-
ibility of select functionality with our silane reagent. 
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IV. Reagent Preparation 
As first reported by our group in 2003,15 preparation of the diamine controller required 
column chromatography for purification, which would be unworkable on kilogram scale 
(Scheme 1.6). To address this issue, we decided to target the bis-HCl salt of the diamine 
for purification, as this solid was conveniently insoluble in both water and ether. Thus, by 
simple washing, all byproducts from the reductive amination step can be easily removed. 
Further, the bis-HCl diamine was found to be bench-stable and non-hydroscopic and thus, 
with these modifications, half-kilogram batches of the diamine controller can routinely be 
prepared. 
Scheme 1.6: Comparison of Procedures for Diamine Preparation  
 
 
Next, we proceeded to optimize (1) the preparation of the crotyl-trichlorosilanes, (2) their 
complexation to the diamine controller, (3) the re-crystallization of the crotylsilanes, and 
(4) the addition of Sc(OTf)3 to afford a 25:1 molar ratio "EZ-Mix" (Scheme 1.7). Again, 
these reactions have been scaled such that 100-gram batches of the diamine reagents can 
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Scheme 1.7: EZ-Mix Preparation 
 
Due to the ease of reagent preparation, we have commercialized our technology with Ge-
lest and Sigma-Aldrich. The material cost of the reagents is between $1-3/g (~2 mmol/g) 
of which approximately half is from the chiral diaminocyclohexane itself.e We hope that 
this low cost combined with the practicality and scope of the reaction will result in an at-
tractive alternative to more established crotylation reagents. 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
e By comparison, the Sigma-Aldrich prices (7/2013) for the Brown Ipc reagent are as follows: Ipc2B-OMe 
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V. Stereochemical Model 
Houk has computationally studied the origins of stereoselectivity in our crotylation reac-
tion, and his results are summarized in Figure 1.5.16 The calculations reveal: (1) reactions 
proceed concertedly through a pentacoordinate silicon in which the aldehyde approaches 
apically and (2) chair-like transition states are 10 kcal/mol lower in energy than boat-like 
transition states. With these provisions, 4 possible transition states were evaluated. 
Transition states III / IV were immediately discounted because of an unfavorable 
electrostatic repulsion between the aldehyde and chloride lone pairs. Further, a stabilizing 
anomeric effect between the aldehyde lone pair and Si-Cl σ* can only occur in TS I / II, 
which is reflected in a 0.1Å longer Si-Cl bond length.f 
Figure 1.5: Strained Silane Allylation: Transition State Calculations 
 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
f In TS III / IV, an anomeric effect between the aldehyde lone pair and Si-N antibonding orbital can occur. 
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To distinguish between transition states I and II, consider that the two diamine nitrogens 
are hybridized with lone pairs directed toward opposite sides of the plane defined by the 
Si, O, and N atoms. Therefore, in TS II, there exists an unfavorable electron-pair repul-
sion between the axial N and chloride whereas in TS I, this repulsion occurs between the 
equatorial N and chloride. Due to the trigonal bypyramidal geometry, this latter interac-
tion in TS I is alleviated because of the larger intervening space. TS I is thus favored. 
Chloride is the key stereochemical control element that enables differentiation be-
tween TS I-IV. Interestingly, when the chloride is replaced with a methyl group, no enan-
tioselectivity is predicted by computation; further, when the chloride is replaced with an 
alkoxy group (i.e. OMe, OPh, OTf), a reduction in enantioselectivity is experimentally 
observed, presumably because (a) oxygen is a smaller atom with lone pairs held "more 
tightly" than those of chloride and (b) Si-O σ* is a weaker acceptor for delocalization of 
the aldehyde lone pair.17 For a stronger chiral controller, one that can deliver the anti-anti 
configuration of Scheme 1.4 for example, an atom (X) with a larger electron cloud and 
increased Si-X σ* acceptor capacity (i.e. X = bromine) could potentially be investigated. 
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VI. Total Synthesis of Zincophorin:6 
To demonstrate our group's crotylation methodology, a short 5-step synthesis of the C17-
C25 fragment of Zincophorin was accomplished, featuring two applications of the "EZ-
Mix" reagent (Scheme 1.7).g Further, oxidation state adjustment via tosylate reduction 
delivered a lone methyl stereocenter (C22); this strategy of crotylation / deoxygenation 
toward isolated stereocenters represents an alternative to chiral auxiliary mediated alkyla-
tions.18 
Scheme 1.7: A 5-Step Synthesis of the C17-C25 Fragment of Zincophorin  
 
 
Completion of Zincophorin occurred in a highly trans-selective Julia-Kocienski olefina-
tion for which extensive screening identified the optimal base, solvent, and unexpectedly, 
C19 protecting group (Scheme 1.8). Evidently, the PMB protected C19 hydroxyl is more 
effective than the analogous TBS compound at promoting high E:Z selectivity (14:1 vs. 
2:1).h Subsequent deprotection then delivered Zincophorin. 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
g A postdoctoral associate, Dr. Tyler Harrison, synthesized the C1-C16 fragment. 
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Scheme 1.8: Completion of the Synthesis of Zincophorin 
 
Our synthesis was completed in ~30 total steps (~20 fewer than all three previous synthe-
ses19–21), demonstrating the utility of the crotylation reaction toward complex polypropi-
onate natural products. To fully leverage this reaction, however, it is necessary that the 
resulting products can seamlessly dovetail into the overall synthetic route. To that end, 
our synthesis showcases many examples of how to use crotylation adducts. Exemplars of 
such alkene functionalization reactions are depicted in Scheme 1.9. 
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VI. Conclusion 
This chapter describes the use of scandium triflate as an effective catalyst for our group's 
crotylsilane reagents. The significance of this discovery is that our method now has a 
broader substrate scope than any other asymmetric crotylation methodology. Further, be-
cause our reagents are so easily prepared and because the reaction conditions are so mild, 
we can also lay claim to having the most processable method as well. Lastly, because the 
crotylation reaction delivers adducts that are central to the structure of polyketide natural 
products, we now have a natural entry point into their total syntheses. 
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VII. Supporting Information 
1. General Information: See the list of abbreviations section for standard abbreviations 
of chemicals and protecting groups. Reactions in anhydrous solvents were conducted un-
der an atmosphere of nitrogen in flame-dried glassware with magnetic stirring unless oth-
erwise indicated. Degassed solvents were purified by passage through an activated alu-
mina column under an argon atmosphere. Thin-layer chromatography (TLC) was carried 
out on glass backed silica gel TLC plates (250 mm) from Silicycle. GC (gas chromatog-
raphy) analysis was performed on a Hewlett-Packard 6890 Series Gas Chromatograph 
equipped with a flame ionization detector (FID using either a Supelco β-Dex 120 
(30x0.25 mm) or Supelco β-Dex 325 (30x0.25 mm) column. HPLC (high performance 
liquid chromatography) analysis was performed on an Agilent 1200 Series using either a 
Chiralpak AD-H (250x4.5 mm ID) column or Chiralcel OD-H (250x4.5 mm ID) column. 
1H-NMR spectra were recorded on a Bruker AVIII 300 (300 MHz), AVIII 400 (400 
MHz), AVIII 500 (500 MHz), or AVIII 500 Ascend (500 MHz) spectrometer. 1H NMR 
chemical shifts (δ) are reported in parts per million (ppm) relative to residual protonated 
solvent peak (CDCl3, 7.26 ppm): multiplicity (bs= broad singlet, s = singlet, d = doublet, 
t = triplet, m = multiplet); coupling constant; integration. Proton decoupled 13C-NMR 
spectra were recorded on a Bruker AVIII 400 (100 MHz), AVIII 500 (125 MHz) or 
AVIII 500 Ascend (125 MHz) spectrometer and are reported in ppm from CDCl3 internal 
standard (77.16 ppm). Infrared spectra (IR) were recorded on a Nicolet Avatar 370DTGS 
FT-IR. Optical rotations were recorded on a Jasco DIP-1000 digital polarimeter. High-
resolution mass spectra were obtained from the Mass Spectrometry Laboratory at Co-
lumbia University. 
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2. Experimental Procedures: Most compounds in Chapter 1 have been previously char-
acterized and reported.5,6 Select experimental procedures are reproduced herein. 
 
EZ-Mix Preparation (with Dr. Hyunwoo Kim): The syntheses of cis and trans-crotyl-
trichlorosilanes have been reported.22 Cis/Trans mixtures of 1,2-diaminocyclohexane 
(DACH) are commercially available for ~$30/L. Resolution with L- or D-tartaric acid 
provides access to (R,R)- or (S,S)-1,2-diaminocyclohexane, respectively. Because unnatu-
ral D-tartaric acid is relatively expensive, particularly in high enantiomeric purity (>99% 
ee), it is our general practice to resolve the cis/trans mixture for the (R,R)-adduct and pur-
chase (S,S)-DACH (Chem-Impex $360/100g). 
 
 
Resolution of 1,2-Diaminocyclohexane: A 5 L three-neck round-bottom-flask, equipped 
with an overhead stirrer, was charged with cis/trans 1,2-diaminocyclohexane (500 g, 4.38 
mol, 1 equiv) and distilled water (1 L). The mixture was heated to 80 °C. A solution of L-
tartaric acid (329 g, 2.19 mol, 0.5 equiv) in distilled water (0.5 L) was added in one por-
tion, followed by glacial acetic acid (276 mL, 4.82 mol, 1.1 equiv). Heating was discon-
tinued, and the mixture was allowed to slowly cool to room temperature. Upon cooling, 
white crystals began to form. The flask was left at room temperature overnight. The re-
sulting mixture was filtered over a 2 L glass funnel of medium porosity. The solid was 
washed with distilled water (3x500 mL) and dried to afford (R,R)-1,2-DACH-L-tartrate 




L-Tartaric Acid (0.5 equiv)
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1,2-DACH Reductive Amination: To a solution of (S,S)-1,2-DACH (30.0 g, 263 mmol, 
1 equiv) in MeOH (650 mL) was added p-bromobenzaldehyde (97.2 g, 525 mmol, 2 
equiv). After 3h, NaBH4 (22 g, 582 mmol, 2.2 equiv) was added portionwise over 30 min 
at 0 °C. The reaction mixture was allowed to warm to room temperature. After 15h, the 
reaction mixture was quenched at 0 °C with distilled water (100 mL) and concentrated. 
The resulting oil was re-dissolved in distilled water (300 mL) and Et2O (400 mL). 12M 
HCl was slowly added at 0 °C until the aqueous layer had a pH less than 2. The resulting 
mixture was vigorously stirred for 1h and filtered over a 2 L glass funnel of medium po-
rosity. The solid was washed with 1M HCl (200 mL) and Et2O (2x200 mL) and dried to 
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Note: The crotylsilane is moisture-sensitive. All steps should be performed under a nitro-
gen atmosphere. The reagents are typically stored in a dry box. To a cooled (0 °C) solu-
tion of diamine controller (20 g, 38.1 mmol, 1 equiv) in CH2Cl2 (127 mL, 0.3 M) was 
added freshly-distilled DBU (22.8 mL, 152 mmol, 4 equiv), followed by cis or trans-
crotyl-trichlorosilane (42.0 mmol, 1.1 equiv). The reaction mixture was allowed to warm 
to room temperature. After 3h, the reaction mixture was concentrated. The resulting oil 
was dissolved in pentane (150 mL) and vigorously stirred for 1h to precipitate the DBU-
HCl salts. The pentane solution was then transferred to a dry round-bottom-flask using 
teflon tubing (3/16 i.d.) equipped with a glass microfiber filter (Grade GF/D). The DBU-
HCl salts were washed with additional pentane (2x100 mL) that was transferred as well. 
The pentane solution was then concentrated to afford crude crotylsilane. Purification was 
accomplished by crystallization. For the trans-crotylsilane, the crude oil was dissolved in 
pentane (38 mL, 1M) and cooled to -20 °C overnight; the pentane was then removed to 
afford product as a white powder (75-80% yield). For the cis-crotylsilane, the crude oil 
was dissolved in pentane (10 mL, 3.8 M) and cooled to -20 °C overnight; the pentane was 
















	   20 
General procedure for the Sc(OTf)3-catalyzed crotylation of aldehydes 
 
Note: The crotylsilane is moisture-sensitive and typically stored in a dry box. However, 
in dry environments, it can be handled in air without noticeable degradation. To a cooled 
(0 °C) solution of the aldehyde (0.30 mmol, 1 equiv.) in CH2Cl2 (3 mL, 0.1 M) was add-
ed crotylsilane (205 mg, 0.36 mmol, 1.2 equiv) followed by Sc(OTf)3 (7.4 mg, 0.015 
mmol, 0.05 equiv). The reaction mixture was stirred vigorously at 0 °C. In most cases, 
the reaction is complete within 1h as monitored by 1H-NMR. HCl workup: The reaction 
mixture was concentrated, re-suspended in Et2O (5 mL, ethanol free), and quenched at 0 
°C with 1M HCl (3 mL). After 1h, the white precipitate was filtered and dried to recover 
bis-HCl diamine (>90% yield). The aqueous layer was separated and extracted with Et2O 
(2x5 mL). The combined organic layers were washed with saturated aqueous NaHCO3, 
dried over MgSO4, filtered, and concentrated. Purification was accomplished by silica gel 
flash column chromatography. TBAF workup: The reaction mixture was quenched at 0 
°C with TBAF-3H2O (1 equiv, 0.30 mmol, 95 mg). After 30 min, the reaction mixture 








	   21 
Chapter 1 References 
(1)  Staunton, J.; Weissman, K. J. Polyketide biosynthesis: a millennium review. Nat. 
Prod. Rep. 2001, 18, 380–416. 
(2)  Khosla, C.; Tang, Y.; Chen, A. Y.; Schnarr, N. A.; Cane, D. E. Structure and 
Mechanism of the 6-Deoxyerythronolide B Synthase. Ann. Rev. Biochem. 2007, 
76, 195–221. 
(3)  Yus, M.; González-Gómez, J. C.; Foubelo, F. Catalytic Enantioselective Allylation 
of Carbonyl Compounds and Imines. Chem. Rev. 2011, 111, 7774–7854. 
(4)  Yus, M.; González-Gómez, J. C.; Foubelo, F. Diastereoselective Allylation of 
Carbonyl Compounds and Imines: Application to the Synthesis of Natural 
Products. Chem. Rev. 2013, 113, 5595–5698. 
(5)  Kim, H.; Ho, S.; Leighton, J. L. A More Comprehensive and Highly Practical 
Solution to Enantioselective Aldehyde Crotylation. J. Am. Chem. Soc. 2011, 133, 
6517–6520. 
(6)  Harrison, T. J.; Ho, S.; Leighton, J. L. Toward More “Ideal” Polyketide Natural 
Product Synthesis: A Step-Economical Synthesis of Zincophorin Methyl Ester. J. 
Am. Chem. Soc. 2011, 133, 7308–7311. 
(7)  Hackman, B. M.; Lombardi, P. J.; Leighton, J. L. Highly Diastereo- and 
Enantioselective Reagents for Aldehyde Crotylation. Org. Lett. 2004, 6, 4375–
4377. 
(8)  Schmidt, D. R.; Park, P. K.; Leighton, J. L. Approach to the Synthesis of 
Dolabelides A and B: Fragment Synthesis by Tandem 
Silylformylation−Crotylsilylation. Org. Lett. 2003, 5, 3535–3537. 
(9)  Roush, W. R.; Palkowitz, A. D.; Ando, K. Acyclic diastereoselective synthesis 
using tartrate ester-modified crotylboronates. Double asymmetric reactions with 
.alpha.-methyl chiral aldehydes and synthesis of the C(19)-C(29) segment of 
rifamycin S. J. Am. Chem. Soc. 1990, 112, 6348–6359. 
(10)  Roush, W. R.; Grover, P. T. N,N’-Bis(2,2,2-trifluoroethyl)-N,N'-
ethylenetartramide: An Improved Chiral Auxiliary for the Asymmetric 
Allylboration Reaction. J. Org. Chem. 1995, 60, 3806–3813. 
(11)  Rauniyar, V.; Hall, D. G. Catalytic Enantioselective and Catalyst-Controlled 
Diastereofacial-Selective Additions of Allyl- and Crotylboronates to Aldehydes 
Using Chiral Brønsted Acids. Angew. Chem., Int. Ed. 2006, 118, 2486–2488. 
	   22 
(12)  Chemler, S. R.; Roush, W. R. Concerning the Synthesis of the Elusive anti,anti-
Dipropionate Stereotriad via the Crotylation of β-Hydroxy α-Methyl Aldehydes 
with (Z)-Crotyltrifluorosilane. Application to the Synthesis of the C(7)−C(16) 
Segment of Zincophorin. J. Org. Chem. 1998, 63, 3800–3801. 
(13)  Chemler, S. R.; Roush, W. R. Stereochemically divergent pathways for the 
allylation and crotylation reactions of anti- and syn-β-hydroxy-α-methyl aldehydes 
with allyl- and crotyltrifluorosilanes. Tetrahedron Lett. 1999, 40, 4643–4647. 
(14)  Chemler, S. R.; Roush, W. R. Stereochemistry of the Allylation and Crotylation 
Reactions of α-Methyl-β-hydroxy Aldehydes with Allyl- and 
Crotyltrifluorosilanes. Synthesis of anti,anti-Dipropionate Stereotriads and 
Stereodivergent Pathways for the Reactions with 2,3-anti- and 2,3-syn-. J. Org. 
Chem. 2003, 68, 1319–1333. 
(15)  Kubota, K.; Leighton, J. L. A Highly Practical and Enantioselective Reagent for 
the Allylation of Aldehydes. Angew. Chem., Int. Ed. 2003, 42, 946–948. 
(16)  Zhang, X.; Houk, K. N.; Leighton, J. L. Origins of Stereoselectivity in Strain-
Release Allylations. Angew. Chem., Int. Ed. 2005, 44, 938–941. 
(17)  Alabugin, I. V; Zeidan, T. A. Stereoelectronic Effects and General Trends in 
Hyperconjugative Acceptor Ability of σ Bonds. J. Am. Chem. Soc. 2002, 124, 
3175–3185. 
(18)  Song, Z.; Lohse, A. G.; Hsung, R. P. Challenges in the synthesis of a unique 
mono-carboxylic acid antibiotic, (+)-zincophorin. Nat. Prod. Rep. 2009, 26, 560–
571. 
(19)  Danishefsky, S. J.; Selnick, H. G.; Zelle, R. E.; DeNinno, M. P. Total synthesis of 
zincophorin. J. Am. Chem. Soc. 1988, 110, 4368–4378. 
(20)  Defosseux, M.; Blanchard, N.; Meyer, C.; Cossy, J. Total Synthesis of 
Zincophorin and Its Methyl Ester. J. Org. Chem. 2004, 69, 4626–4647. 
(21)  Komatsu, K.; Tanino, K.; Miyashita, M. Stereoselective Total Synthesis of the 
Ionophore Antibiotic Zincophorin. Angew. Chem., Int. Ed. 2004, 116, 4441–4445. 
(22)  Suen, L. M.; Steigerwald, M. L.; Leighton, J. L. A new and more powerfully 
activating diamine for practical and scalable enantioselective aldehyde 
crotylsilylation reactions. Chem. Sci. 2013, 4, 2413–2417. 
(23)  Kennedy, J. W. J.; Hall, D. G. Dramatic Rate Enhancement with Preservation of 
Stereospecificity in the First Metal-Catalyzed Additions of Allylboronates. J. Am. 
Chem. Soc. 2002, 124, 11586–11587. 
	   23 
(24)  Yu, S. H.; Ferguson, M. J.; McDonald, R.; Hall, D. G. Brønsted Acid-Catalyzed 
Allylboration: Short and Stereodivergent Synthesis of All Four Eupomatilone 
Diastereomers with Crystallographic Assignments. J. Am. Chem. Soc. 2005, 127, 
12808–12809. 
(25)  Rauniyar, V.; Zhai, H.; Hall, D. G. Catalytic Enantioselective Allyl- and 
Crotylboration of Aldehydes Using Chiral Diol•SnCl4 Complexes. Optimization, 
Substrate Scope and Mechanistic Investigations. J. Am. Chem. Soc. 2008, 130, 
8481–8490. 
(26)  Evans, D. A.; Nagorny, P.; McRae, K. J.; Sonntag, L.-S.; Reynolds, D. J.; 
Vounatsos, F. Enantioselective Synthesis of Oasomycin A, Part III: Fragment 
Assembly and Confirmation of Structure. Angew. Chem., Int. Ed. 2007, 46, 545–
548.  
 











	   	  
	   25 
I. Introduction 
Crotylation reactions set vicinal stereocenters and therefore, provide a natural strategy for 
the synthesis of adducts bearing an even number of contiguous stereocenters (Scheme 
2.1A). However, a recurring structural motif in polyketides is a stereotriad consisting of 
methyl, hydroxyl, and methyl stereocenters (Scheme 2.1B). To build such fragments, a 
source for the third stereocenter needs to be identified. 
In Chapter 1, the crotylation of Roche ester-derived aldehydes was presented as a 
means toward such motifs (Scheme 2.1C), and since its introduction by Roush in 1987,1 
this strategy remains the method of choice.2 Despite what might be assumed based on its 
widespread usage, however, the Roche ester strategy lacks both redox and step-economy. 
The ester must first be protected and reduced and after crotylation, be re-functionalized to 
support further chemistry (Scheme 2.1C). The entire sequence takes at least 6 steps, only 
one of which productively forms a carbon-carbon bond. As a starting material, the Roche 
ester simply lacks the functionality needed for the rapid buildup of dense stereochemical 
complexity. 
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II. Prior Group Stereotriad Methodology 
Our group's contribution toward developing more efficient stereotriad strategies began in 
early work (ca. 2000) on a silylformylation – allylation tandem reaction (Scheme 2.2).3–5 
This sequence begins by tethering a bis-allylsilane and homo-propargylic alcohol. Under 
Rh catalysis in the presence of CO, the alkyne undergoes an intramolecular silylformyl-
ation whereupon one of the diastereotopic allyl groups is preferentially transferred to the 
newly-formed aldehyde. The resultant vinylsilane is then subjected to a Tamao oxidation 
which first delivers an enol before tautomerization to the ketone. 
Scheme 2.2: Intramolecular silylformylation – allylation reaction 
 
This reaction sequence can assume many forms but in its original and most basic logic, a 
homo-propargylic alcohol is converted to a 1,5-diol, with 1,5-anti induction (Scheme 
2.3A).3 Subsequently, our group incorporated additional stereochemical (α, β, γ) patterns 
to afford stereotriad-containing adducts (Scheme 2.3B).6 
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In particular, consider the anti-anti stereotriad (Scheme 2.3B). Here, because the starting 
material is an internal alkyne, the enol tautomerization step delivers an additional methyl-
bearing stereocenter. To rationalize this protonation and resulting anti-anti selectivity, we 
have postulated that under the conditions of the Tamao oxidation, minimization of non-
bonding interactions is paramount, resulting in the conformation depicted in Figure 2.1A. 
Protonation then occurs from the sterically less-hindered face, presumably guided by the 
pendant hydroxyl group. 
Figure 2.1: Transition States for Enol Tautomerization: (A) anti-anti; (B) syn-anti 
 
However, it turned out that the anti-anti stereotriad was the only stereochemical pattern 
that could reliably be generated. Extensive work went into developing 1,5-syn,7 α–β syn,8 
and β–γ syna protocols but unfortunately, these protocols did not result in high selectivity 
with broad applicability. For example, in the context of our group's epothilone studies,8 
Tamao oxidative conditions were identified to access the α–β syn permutation. The logic 
was to enforce a substrate conformation in which internal hydrogen bonding becomes the 
paramount control element (Figure 2.1D). However, as shown in Figure 2.2, high α–β syn 
selectivity has to date only been observed for one substrate. 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
a In principle, this β–γ syn relationship should be trivial to access by employing the bis-trans-crotylsilane. 
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Figure 2.2: α–β Syn Tamao Products (dr refers to α stereocenter) 
Because the successful control of all 8 permutations of α, β, and γ was relevant to several 
total syntheses in our group, we decided to revisit our stereotriad approach and solve this 
generalizability problem. As will be described in this chapter, we were eventually able to 
access all 8 combinations of α, β, and γ by abandoning our reliance on internal substrate 
control and independently setting each stereocenter through external reagent control. 
 The first example of successful reagent control was with the 1,5-diol relationship 
(Scheme 2.3A). The inherent 1,5-anti induction between these two alcohols is due to the 
rigid geometry of intramolecular allyl delivery: one of the diastereotopic allyl groups is 
predisposed to add into the aldehyde (Scheme 2.4A). However, consider replacing the 
allyl groups with non-transferrable groups, i.e. Ph (Scheme 2.4B). This would result in a 
β-silyl unsaturated aldehyde, which was shown to be a viable substrate for intermolecular 
allyl- and crotylation in Chapter 1 (Scheme 1.3). Further, we amply demonstrated that our 
EZ-Mix reagents can override most any diastereofacial bias of the aldehyde. Strategically 
then, if one moves from internal (substrate-control) to external (reagent-control) allyl 
delivery, complete control of the β and γ stereocenters can be realized. 
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Still, external allyl delivery does not address the α stereocenter, which is defined upon 
vinylsilane oxidation, during enol–ketone tautomerization (Figure 2.1). The selectivity 
for this protonation step is substrate-controlled and involves a network of in-plane 1,3 
interactions and hydrogen bonding. Multiple effects combine to produce the sense of 
selectivity and therefore, small changes can disrupt the delicate network. While a holy 
grail in this manifold would be to identify two Tamao oxidations (α–β syn, α–β anti), 
given the potential demands of the vinylsilane substrate (including varied substitution 
patterns) and the relatively few Tamao protocols reported in the literature, this might not 
even be possible (Figure 2.2). 
 Therefore, to solve the α stereocenter problem, we sought to bypass the Tamao 
oxidation altogether. Because the vinylsilane is not actually present in the product and 
only serves as a masked ketone, we envisioned two alternative approaches outlined in 
Schemes 2.5B and C: (a) direct incorporation of the ketone prior to crotylation (Section 
III of this chapter) and (b) ketone surrogates that would not require oxidative removal 
(Section IV). Naturally, these two approaches present their own unique challenges (vide 
infra), but our inclination was that the Tamao approach had run its course. 
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Ultimately, with the dioxolane construct depicted in Scheme 2.5C, the α stereocenter was 
independently set in the starting material prior to crotylation, which itself sets the β and γ 
stereocenters. In this manner, we were able to access all 8 stereotriad patterns. 
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III: Studies in the Crotylation of β-Keto Aldehydes 
A compelling approach toward stereotriad adducts would be to directly crotylate a β-keto 
aldehyde (Scheme 2.5A). If successful, this reaction would deliver in one step the same 
adduct that took at least six steps from the Roche ester. In this proposal, the enol tautomer 
of the β-keto aldehyde would add into a crotylsilane, followed by crotylation of the more 
reactive aldehyde (Curtin-Hammett kinetics, Scheme 2.5B). The resultant silyl enol ether 
would then undergo protonation upon workup. 
Scheme 2.5: Proposed β-Keto Aldehyde Crotylation 
 
Of course, there are immense challenges because the reaction must be regio-, diastereo-, 
and enantioselective. Nevertheless, the proposal finds precedent in prior group work on 
the allylation of a class of ketones bearing a pendant hydroxyl group (Scheme 2.6A).9,10 
In particular, β-diketones have been shown to be viable substrates to afford chiral tertiary 
carbinols.10 Here, an equilibrium exists between the diketone and enol tautomers, as well 
as in the initially-formed silyl enol ether isomers (Scheme 2.6B, shown in the case of 2-
acetyl-1-tetralone). However, Curtin-Hammett kinetics govern the reaction and therefore, 
despite the multitude of intermediates, high regioselectivity may be obtained. Our idea, 
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Scheme 2.6: Prior Work on Ketone Crotylation 
 
 
Substrate Preparation: The β-keto aldehydes were prepared via Claisen condensation and 
initially isolated as the sodium salts (Scheme 2.7).11 Protonation of the salt by HCl (Et2O) 
followed by vacuum distillation then yielded the actual compounds, which were found to 
be reasonably stable if stored at -20 °C. At room temperature, the aldehydes appeared to 
trimerize to their aromatic counterparts within one day. 












R = alkyl, aryl
58-90%, 81-95% ee
R3
























































not observed by 1H-NMR.
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Treatment of a β-keto aldehyde with the cis-crotylsilane delivered only the regioisomeric 
stereotriad arising from aldehyde crotylation (Scheme 2.8A). No products derived from 
ketone crotylation could be observed, demonstrating this reaction to also be governed by 
Curtin-Hammett kinetics (Scheme 2.5B). The selectivity of the α stereocenter was 7:1, as 
proven via syn-selective reduction and acetonide formation (Scheme 2.8B). However, the 
reaction yield was low (<20%) and rather irreproducible, and the product was racemic.  
Scheme 2.8: Initial β-Keto-Aldehyde Crotylation Reaction 
 
 
We considered that a background racemic pathway could be responsible for the low yield 
and ee. For example, multiple aldehydes could add into the crotylsilane and displace the 
chiral controller before the rate-determining crotylation event takes place (Scheme 2.9). 
In support of this hypothesis, free diamine was observed by 1H-NMR.  
























































































	   34 
To minimize this racemic pathway, we explored various mechanisms to limit the amount 
of free β-keto aldehyde in solution. However, neither (a) slow addition of the aldehyde 
into a solution of crotylsilane nor (b) using a large excess of crotylsilane nor (c) lowering 
the concentration (0.1M to 0.01M) was effective in minimizing the background reaction. 
Our first lead came from the addition of AgOTf (Scheme 2.10A). This additive 
has been used in our group as a way of increasing the reactivity of chlorosilanes.10,12 The 
idea is to quickly convert free β-keto aldehyde into a silyl enol ether, thereby removing 
the offending species from solution. In addition, a stronger acid would be formed (triflic 
vs. hydrochloric), and to the extent that protonation of the diamine backbone increases 
the silicon Lewis acidity, the rate of crotyl transfer could be expected to increase as well. 
Scheme 2.10: (A) AgOTf as Additive; (B) Screen to Improve Diastereoselectivity 
 
With the AgOTf additive, a well-behaved system was obtained. The stereotriads were 
reliably being generated in ~60% yield and ~40% ee. The remainder of the mass balance 




























Other Workups Screened: MeLi, then AcOH; MeOH; CSA, MeOH; PPTS/iPrOH; KF, MeOH; 
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A screen of workup conditions revealed that TBAF could deliver product with a 2:1 dr (α 
stereocenter) whereas KHCO3/iPrOH could reverse the sense of selectivity and provide 
the opposite isomer in 96:4 dr (Scheme 2.10B). These product ratios were presumed to be 
kinetic in origin because treatment of product to the workup conditions resulted in no dr 
change. Thus, with leads to resolve both the yield and diastereoselectivity, attention was 
directed towards improving the ee. 
Because we observed a clear beneficial effect in changing counterions from Cl to 
OTf (0% to 40% ee), further counterion optimization was thought to be possible. Indeed, 
the literature is full of examples of more non-coordinating counterions resulting in higher 
enantioselectivity in asymmetric reactions.13 However, a screen of silver salts revealed no 
discernable trend (Scheme 2.11). SbF6 was found to deliver the highest ee at 61% but this 
result was rather irreproducible and dependent on the quality of SbF6, presumably from 
small amounts of hydrolysis and fluoride leakage. 
Scheme 2.11: Screen to Improve Enantioselectivity 
 
60%, 2:1 dr, 40% ee
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To date, 61% ee is the highest recorded with our diamine controller. However, it did not 
solve our ee problem and in the long-term, by employing stoichiometric amounts of an 
antimonate salt, created a new one. Remember that our goal was a convenient and rapid 
synthesis of stereotriads; instead, we found ourselves inching toward a reaction that even 
if it worked, would not be processable. 
Thus, we decided to take a step back and return to our initial hypothesis regarding 
the racemic background pathway (Scheme 2.9): multiple aldehydes displacing the chiral 
diamine controller. In this scenario, the weak Si-N bonds of the diamine controller (BDE 
76 kcal/mol) could be facilitating displacement, particularly if compared to the stronger 
Si-O bonds (108 kcal/mol) of a hypothetical diol-based controller. We therefore sought to 
explore the landscape of these diol-based silane reagents. 
When pinacol was employed as the controller, the crotylation reaction effectively 
delivered products in >70% yield and importantly, the reaction worked with the Na salt 
of the β-keto aldehyde (Scheme 2.12A). Because the Na salts were significantly easier to 
prepare than the protonated versions, this result represented an important advance in our 
goal of realizing a user-friendly reaction. 
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While these pinacol reactions were racemic, they nonetheless validated our hypothesis of 
using Si-O bonds and, in principle, could be rendered asymmetric if either a chiral diol or 
chiral catalyst were used (similar to the role of Sc(OTf)3 in the crotylations of Chapter 1). 
Further, one can imagine chiral N,O controllers that "split the difference" between diols 
and diamines. Indeed, Dr. Wesley Chalifoux found that pseudoephedrine is an effective 
controller for obtaining high enantioselectivity, and the reaction also works with the Na 
salt (Scheme 2.12B). Therefore, with leads to resolve the enantioselectivity problem, my 
focus shifted to a separate stereotriad strategy, described in the following section. 
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IV: Hydroformylation / Crotylation Strategy 
The crotylation of β-keto-aldehydes constitutes a direct reaction to highly functionalized 
stereotriad-containing adducts. Unexpectedly, though, we discovered that we could not 
actually contend with all the functionality this reaction affords. For example, ozonolysis 
of the terminal olefin affords a δ-keto-aldehyde, which can readily cyclize (Scheme 2.13). 
The methyl ketone in the product evidently interferes with subsequent chemistry. While, 
in principle, we could protect this carbonyl group after crotylation, such a protection step 
would undermine the directness of the β-keto-aldehyde approach. 
Scheme 2.13: Instability of a δ-Keto Aldehyde 
 
 
Fortuitously, it was around this time that we began to take note of the hydroformylation 
literature and realize that we could adopt this reaction for our purposes (Scheme 2.14A): 
hydroformylation of an olefin would afford a chiral, branched aldehyde that could in turn 
be crotylated. Further, because many hydroformylation reactions have been rendered 
asymmetric, our α stereocenter problem would be inherently solved. The only constraint 
to this manifold would be that the functional group directing hydroformylation be readily 
convertible to a carbonyl because the carbonyl group uniquely supports further chemistry. 
Accordingly, we evaluated two functional groups: an amide14 and acetal;15 subsequently, 
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Scheme 2.14: Proposed Hydroformylation / Crotylation: (A) Reaction Scheme; (B) 
Candidate Starting Materials 
 
 
Weinreb Amide: Weinreb amides are orthogonal to many reactions conditions but well 
established as synthetic handles toward ketones and aldehydes. Thus, one can imagine 
commercializing the stereotriad-containing adduct depicted in Scheme 2.14 as a multi-
purpose complement to the Roche ester. 
Scheme 2.14: Proposed Weinreb Amide Hydroformylation – Crotylation 
 
 
Professor Matthew Clarke (University of St. Andrews) had previously investigated the 
hydroformylation component of this stereotriad strategy (Scheme 2.15).14 Using Landis' 
phospholane ligand, the aldehydes could be prepared as a single regioisomer in 71% ee. 
Notably, this chiral aldehyde is configurationally stable because enolization would incur 
a penalty from A(1,3) strain of >4 kcal/mol. Further, the moderate ee would, in principle, 
not be problematic for our purposes because it could be upgraded in the crotylation step. 
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However, upon treatment of the branched aldehyde with our EZ-Mix reagent, the desired 
product could only be isolated in trace amounts (Scheme 2.16). Evidently, the amide is 
incompatible with our crotylsilane platform, perhaps because after crotylation, the still 
Lewis acidic silicon can activate the amide in a retro-aldol pathway. Nevertheless, as a 
proof-of-concept to establish the viability of vinyl Weinreb amides as starting materials, 
stereotriads can be obtained upon reaction with Batey's crotylborate (Scheme 2.16).17 
Future work in this area could therefore be directed toward chiral boron reagents, in order 
to upgrade the enantioselectivity from the hydroformylation step. 
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Dioxolane: In tandem with the amide studies, commercially available vinyl dioxolanes 
were also evaluated as candidate substrates. Here, too, the hydroformylation component 
had been addressed: Landis had reported conditions to deliver the branched aldehydes in 
excellent (>90% ee) enantioselectivity (Scheme 2.17).15 
Scheme 2.17: Vinyl Dioxolane Hydroformylation Precedent 
 
When these aldehydes were treated with our EZ-Mix reagents, the stereotriad-containing 
adducts were obtained in high yields and selectivities (Scheme 2.18). Two stereochemical 
permutations are shown but due to the comprehensive nature of our crotylsilane platform, 
all arrays should be possible. Further, depending on the choice of workup (TBAF; HCl), 
one can deprotect the acetal immediately or maintain the carbonyl group in its masked 
form. Thus, added flexibility is given in the timing of the deprotection step. Finally, we 
realized our goal of a rapid and efficient stereotriad synthesis. 
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V. Conclusion 
Chapter 2 describes the evolution of our group's efforts to access stereotriad-containing 
fragments (Scheme 2.19). On the whole, the hydroformylation / crotylation strategy has 
proven most general because it offers full control over all stereochemical permutations. 
The significance of this result will be demonstrated in Chapter 3, wherein we were able to 
accomplish a 14-step synthesis of the complex polyketide Dictyostatin. 
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VII. Supporting Information 
Experimental Procedures 
 
To a cooled (0 °C) solution of aldehyde15 (420 mg, 3.2 mmol, 1 equiv) in CH2Cl2 (32 
mL, 0.1 M) was added (S,S)-cis-crotylsilane (2.2 g, 3.9 mmol, 1.2 equiv) and Sc(OTf)3 
(159 mg, 0.32 mmol, 10 mol%). After 90 min, the reaction mixture was quenched with 
TBAF (3.9 mL, 1M THF). After 30 min, the reaction mixture was concentrated and 
directly purified by silica gel flash column chromatography (10-25% EtOAc/Hex) 
affording the anti-syn-stereotriad (420 mg, 70% yield) as a colorless oil. TLC Rf = 0.28 
(20% EtOAc/Hex); [α]21D -3.1 (c = 1.0, CH2Cl2); IR (thin film) 3523, 2974, 2886, 1636, 
1458, 1401, 1113, 1044, 999, 965, 924 cm-1; 1H NMR (500 MHz, CDCl3) δ 5.91 (ddd, J 
= 17.4, 10.4, 7.0 Hz, 1H), 5.11 – 5.04 (m, 2H), 4.96 (d, J = 4.0 Hz, 1H), 4.03 – 3.95 (m, 
2H), 3.92 – 3.83 (m, 2H), 3.57 (app. dt, J = 7.8, 3.8 Hz, 1H), 3.01 (d, J = 3.5 Hz, 1H, 
OH), 2.41 – 2.34 (m, 1H), 1.99 (app. pd, J = 7.1, 4.0 Hz, 1H), 1.03 (d, J = 6.8 Hz, 3H), 
0.95 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 142.4, 114.4, 106.6, 75.8, 65.2, 
65.0, 40.3, 39.2, 12.6, 11.3; LRMS: Exact mass calcd for C10H19O3 [M+H]+: 187.13; 
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To a solution of aldehyde15 (3.6 g, 25 mmol, 1 equiv) in CH2Cl2 (125 mL, 0.2 M) was 
added (R,R)-trans-crotylsilane (16g, 29 mmol, 1.15 equiv) and Sc(OTf)3 (610 mg, 1.2 
mmol, 5 mol%). After vigorously stirring for 12h, the reaction mixture was concentrated, 
re-suspended in Et2O (125 mL), and quenched at 0 °C with 1M HCl (75 mL). After 1h, 
the white precipitate was filtered and dried to recover the bis-HCl diamine. The aqueous 
layer was separated and extracted with 50% EtOAc/Hex. The combined organic layers 
were washed with saturated aqueous NaHCO3, dried over MgSO4, filtered, and 
concentrated. Purification was accomplished by silica gel flash column chromatography 
(25% EtOAc/Hex) affording the syn-anti stereotriad (3.5 g, 90% yield) as a colorless oil. 
TLC Rf = 0.30 (30% EtOAc/Hex); [α]21D 4.4 (c = 1.0, CH2Cl2); IR (thin film) 3474, 
2968, 2932, 2877, 1709, 1456, 1421, 1358, 1001, 916 cm-1; 1H NMR (400 MHz, CDCl3) 
δ 5.88 – 5.77 (m, 1H), 5.18 – 5.12 (m, 2H), 3.76 (app. dt, J = 7.4, 3.5 Hz, 1H), 2.70(qd, J 
= 7.1, 4.1 Hz, 1H), 2.32 – 2.25 (m, 2H, C22H, OH), 2.24 (s, 3H), 1.19 (d, J = 7.1 Hz, 3H), 
1.04 (d, J = 6.9 Hz, 3H); 13C NMR (100 MHz, CDCl3) δ 212.7, 140.7, 116.4, 74.5, 49.0, 
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Total Synthesis of Dictyostatina,b 
  
                                                      
a  Prior Dictyostatin studies: Burke,69 Colobert,70 Cossy,71 Curran,72,73 Das,74,75 Dias,76,77 Gennari,78 
Hanson,79 Maier,80,81 Micalizio,82 Paterson,40,62 Ramachandran,46 Phillips.83 For discussion, see Appendix 1. 
b The work described in this chapter was conducted in conjunction with Mr. Cyril Bucher, an undergradu-
ate in the lab. This is noted accordingly where applicable. 
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I. Introduction 
Much of the reaction development described in the previous two chapters was motivated 
by a careful retrosynthetic analysis of Dictyostatin, a polyketide-derived natural product 
that potently inhibits the growth of human cancer cells. This chapter will be confined to 
the challenges of its total synthesis, while a discussion of its biological function is pro-
vided in Appendix 2. 
In Chapter 1, I described the crotylation reaction as a premier method for building 
propionate subunits (Scheme 3.1A); in Chapter 2, I described telescoping hydroformyla-
tion and crotylation reactions as a new paradigm for building stereotriads (Scheme 3.1B). 
In this chapter, I will describe how this methodological arsenal can dramatically simplify 
the synthesis of polyketides. Specifically, we have accomplished a 14-step longest-linear-
sequence synthesis of Dictyostatin, the shortest total synthesis reported to date.1 Further, 
we can rapidly prepare analogs by modifying just one of three modular components, each 
prepared in 4-5 steps. 
Scheme 3.1: Crotylation Methodology as Applied to Dictyostatin 
 
II. Dictyostatin Synthesis Plan 
Our goal was to develop a short, scalable, and diversifiable route that could facilitate the 
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lead to gram quantities of the natural product and toward that end, identified (1) a hydro-
formylation / crotylation sequence for the stereotriads C12-C14 and C20-C22 and (2) a 
crotylation reaction for the C6-C7 propionate subunit (Scheme 3.1C, highlighted in red). 
Given this overall framework, the question turned to how we could integrate our 
crotylation reactions into fragments that could subsequently be coupled; put another way, 
this required identifying a fragment coupling strategy that could readily house our cro-
tylation adducts. In such an analysis, we settled after some initial trials on (1) a Horner 
Wadsworth Emmons (Z)-olefination to set C10/C11, (2) an alkylation to set C16/C17, 
and (3) an esterification reaction to close the macrocycle. This deconstruction conven-
iently afforded 3 fragments of roughly equal complexity. Although I have explicitly iden-
tified functional and protecting groups in Scheme 3.2, I will save addressing these partic-
ulars to the relevant discussion below. 































































III. Iodide C11-C17 
1. C12-C14 Stereotriad. The synthesis of iodide C11-C17 commenced with the hydro-
formylation / crotylation of 2-vinyl-1,3-dioxolane, as described in detail in Chapter 2 and 
outlined again in Scheme 3.3. However, shortly after initiation of our Dictyostatin work, 
Sigma-Aldrich discontinued the sale of the chiral phospholane ligand. Further, its synthe-
sis2 required the preparatory HPLC separation of enantiomers, which our laboratory was 
unequipped to handle. Therefore, because we could no longer buy or make this chiral lig-
and, it appeared as if we would be thwarted on the first step of our route! 
 
Scheme 3.3: Hydroformylation / Crotylation of 2-Vinyl-1,3-Dioxolane 
 
 
Fortunately, we had anticipated this remote possibility and stockpiled one gram of ligand 
for the metaphorical rainy day. Nevertheless, with a ligand loading of 0.55 mol%,3 one 
gram of ligand (MW 1311) would hardly be sufficient to support a long-term synthesis 
project in which gram quantities of Dictyostatin were targeted. Therefore, out first priori-



















































After extensive screening, we were pleased to discover that the ligand loadings could be 
reduced to 0.015 mol% provided (1) the reaction was run neat in dioxolane and (2) the 
temperature was increased from 40 to 70 °C (Scheme 3.4). Although the branched to lin-
ear ratio dropped slightly – from 4.2:1 to 2.5:1 b:l – with this new procedure, more than 
10 grams of branched aldehyde could be obtained using only 30 milligrams of ligand.c 
We had therefore found a solution to our ligand supply problem. 
Scheme 3.4: Optimized Hydroformylation for Low Ligand Loadings 
 
Yet because the branched aldehyde was still quite valuable, we also decided to re-
examine the crotylation step, in order to improve on the 70% yield initially obtained. The 
remainder of the mass balance appeared to be the aldehyde derived from acetal deprotec-
tion (Scheme 3.5). Presumably, the crotyl reagent is sufficiently Lewis acidic to activate 
the acetal for ring opening. 
Scheme 3.5: C12-C14 EZ-Mix Crotylation byproduct 
 
Initially, we probed the intrinsic diastereofacial bias of the chiral aldehyde with the goal 
that a substrate-controlled crotylation could be realized. However, with the achiral cro-
                                                      
c We surmise that the drop in regioselectivity was due to the increase in scale. Specifically, the same sized 
Parr bomb was used for all reactions, and thus the surface area exposed to SynGas was not scaled accord-
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tylboron pinacol reagent, only a 2:1 ratio of diastereomers was obtained (Scheme 3.6A). 
We moved on to discover that a chiral diaminophenol-based reagent, concurrently being 
developed in-house,4 consistently provided product in higher yields (79-88%) and with 
minimal acetal deprotection. However, this new reaction required cryogenic temperatures 
(-78 °C) for optimal dr, and as we scaled up from 1 to 10 grams, we noticed that the chi-
ral controller could no longer be recovered after TBAF workup. This was particularly un-
fortunate because the controller required a multi-step and rather labor-intensive synthesis. 
1H-NMR of the crude material after TBAF treatment suggested a rearrangement had oc-
curred, perhaps via formation of an intermediate quinone methide (Scheme 3.6B). It is 
possible that commercial TBAF sources contain variable amounts of hydroxide that pro-
motes this process. Nevertheless, our group has developed 2 silicon-based crotylation re-
agents that afford the C12-C14 stereotriad. 














































2. C16 Stereocenter: The next challenge in synthesizing the C11-C17 fragment was set-
ting the C16 stereocenter. All previous syntheses adopted an alkylation strategy mediated 
by a chiral auxiliary (Scheme 3.7A). We wanted to avoid such auxiliaries and targeted 
strategies of (1) deoxygenation (Scheme 3.7B) and (2) hydrogenation (Scheme 3.7C).5 
Scheme 3.7: Comparison of Strategies Toward the C16 Stereocenter 
 
Deoxygenation: We were able to prepare the requisite starting material using our scandi-
um-catalyzed crotylation methodology (Scheme 3.8A). However, we quickly discovered 
that (a) the C13 oxygen is sterically too hindered for hydride displacement and (b) radical 
mediated processes result in decomposition, likely from intramolecular 1,5-hydrogen rad-
ical abstraction of the C15 carbon radical to C11 acetal hydrogen (Scheme 3.8B).6 
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Hydrogenation: Mr. Cyril Bucher took the lead in investigating the hydrogenation strate-
gy. He prepared the requisite α,β-unsaturated aldehyde via a cross-metathesis with meth-
acrolein (Scheme 3.9). However, when this aldehyde was treated with either cationic 
rhodium or iridium catalysts, under H2 pressures upwards of 1000 psi, only starting mate-
rial was recovered. We initially found this to be rather surprising but in fact, the literature 
only documents unsaturated esters as competent substrates.7–10 Evidently, unsaturated 
aldehydes do not share the same reactivity profile, presumably because their olefins are 
too electron-poor to bind the cationic metal. Thus, we oxidized11 the aldehyde to the ester 
and selectively reduced this substrate with Crabtree's catalyst.d 
Scheme 3.9: Directed Hydrogenation of Aldehyde vs. Ester 
 
Still, there was a significant and unexpected difference in reactivity (Scheme 3.10): in 
Evans' precedent, the hydrogenation occurs under a balloon pressure of hydrogen, with a 
less reactive rhodium complex (Eq. 1). These conditions are completely ineffective with 
our substrate, which contains an extra dioxolane ring (Eq. 2). Only with a more reactive 
iridium catalyst can product be obtained and then, only under higher H2 pressure for full 
conversion. Moreover, these Ir / 300 psi H2 conditions do not extend to the epi-C12 sub-
strate, which reacts at a substantially slower rate. 
                                                      



















































Scheme 3.10: Comparison of Hydrogenation Reactions 
 
To rationalize these results, consider that cationic metals are known to bind to polar func-
tional groups. With our system, then, it is possible that the alcohol and dioxolane oxygens 
are sequestering the metal, and only under conditions with (1) the more Lewis acidic cat-
alyst (iridium vs. rhodium) and (2) the more electron-rich olefin (ester vs. aldehyde) can a 
metal-pi complex pre-transition state assembly be achieved (Scheme 3.11). 
 Support for this hypothesis comes from comparing the hydrogenation of the C12 
and epi-C12 substrates, the latter of which is substantially less reactive (Scheme 3.11). It 
is remarkable that such a remote stereocenter can have such a dramatic impact on reactiv-
ity. However, if one considers a catalyst resting state in which the iridium is sequestered 
between the two oxygens, then in order for hydrogenation to occur, the unsaturated olefin 
must outcompete the dioxolane oxygen. As the iridium-pi complex forms, a prohibitive 
syn-pentane interaction between the C12 and C14 methyls occurs, and the pre-transition 
state is unable to assemble (Scheme 3.11A). In contrast, this steric penalty is not present 


























































Scheme 3.11: Hydrogenation of (A) epi-C12 and (B) C-12 
 
 
3. Completion of Fragment C11-C18: After setting the C16 stereocenter, a few routine 
transformations delivered the target iodide. Scheme 3.12 depicts the final 5-step route. 
The high efficiency is principally due to the hydroformylation / crotylation sequence and 
the telescoping of several steps as one-pot procedures. Over 15 grams of the penultimate 
compound were produced in a 3-week campaign. 


































































































































Two additional points regarding the C11-C18 iodide bear mention: 
First, in the final analysis, it was decided for economic reasons that a Wittig ole-
fination could better generate the unsaturated ester rather than a cross-metathesis. This is 
due to the high cost of the Hoveyda-Grubbs catalyst and the high catalyst loadings (up to 
10%) required to make hindered trisubstituted olefins. 
Second, should the directed hydrogenation be performed on larger than decagram 
scale, the 2 mol% catalyst loading (which was required for full conversion) should be re-
examined. While this percentage may seem low, Crabtree's iridium catalyst is among the 
more expensive chemicals of the route ($1140/5g). One proposal would be to investigate 
using the BArF counterion (vs. PF6), which has been reported to show increased activity, 




IV. Hydrazone C18-C25 
In an early analysis, we sought to adapt our C12-C14 stereotriad synthesis to a C20-C22 
setting (Scheme 3.13). In principle, this adaptation would require four steps: (1) alcohol 
protection; (2) Wacker oxidation; (3) acetal deprotection; and (4) conversion of the re-
sulting aldehyde to a cis-diene. 
Regarding step (1), we initially chose a PMB group because we wanted a protect-
ing group orthogonal to the C13 TBS. Further, we imagined leveraging the PMB group in 
a chelation-controlled zinc-borohydride reduction of the C19 ketone (Scheme 3.26). Re-
garding step (2), initial Wacker oxidation reactions were low-yielding but delivered suffi-
cient material to validate the subsequent steps. In practice, step (3) could not be realized: 
the acetal could not be cleanly deprotected, presumably because the presence of the me-
thyl ketone results in cyclization of the δ-keto-aldehyde under the reaction conditions. 
Indeed, the δ-keto-aldehyde was eventually prepared via a different route (Scheme 3.17) 
and confirmed to be extremely unstable, even when frozen in benzene at -20 °C. 
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Therefore, we resorted to the Landis hydroformylation of 2-methyl-2-vinyl-1,3-dioxolane 
(Scheme 3.14). Because of our ligand supply problem (Part III) we similarly re-optimized 
the reaction to lower the ligand loadings. 
Scheme 3.14: Optimized Hydroformylation for Low Ligand Loadings 
 
 
1. 1st Generation C18-C25 Fragment Synthesis: After hydroformylation, we subjected 
the branched aldehyde to our EZ-Mix crotylation reagent (Scheme 3.15). In the 1st gen-
eration route, we decided to hydrolyze the dioxolane ring to the methyl ketone because 
(1) an HCl workup is considerably more scalable than a TBAF workup and (2) the cro-
tylation reagent slowly deprotects the ketal anyway (see Chapter 1 for discussion). 
Scheme 3.15: C20-C22 EZ-Mix Crotylation 
 
 
After PMB protection and ozonolysis, installation of the cis-diene was evaluated (Scheme 
3.16). To our knowledge, four cis-dienylation reactions have been advanced in the litera-
ture14–17 but at the outset, it was unclear which method would be applicable to our δ-keto-
aldehyde substrate. To answer this question, we analyzed total syntheses of the related 
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Schreiber, who completed the 1st synthesis in 1993, reported a Stork-Zhao / Negishi cou-
pling (65/79% yield) on an identical δ-keto-aldehyde substrate, but no experimental pro-
cedure was provided.18 Subsequently, in a 2nd generation synthesis (1996), he reported 
the same Stork-Zhao / Negishi sequence but on a different substrate (75/80% yield).19 
Thus, it is unclear whether the original reaction was found to be deficient in some way. 
Paterson reported a Nozaki-Hiyama-Kishi (NHK) / Peterson olefination (94%);14 Myles 
reported a Matteson allylation / Peterson olefination (80%);20 Smith applied Yamamoto's 
olefination protocol (70%, 16:1 Z:E);21 and finally, Novartis, in their 60g Discodermolide 
campaign, optimized Paterson's dienylation sequence to be a one-pot procedure (81%).22 
Initial studies quickly established that only the Wittig/Stille sequence (50% yield, 
10:1 Z:E) would be feasible, as the other methods simply resulted in decomposition. For 
example, the NHK adduct cyclized to the 6-membered hemiacetal, which upon treatment 
of base, failed to undergo ring-opening and Peterson olefination (Scheme 3.16B) 
Scheme 3.16: Initial Dienylation Studies Toward C22-C25 
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However, upon attempts to optimize the Wittig/Stille sequence, this method, too, present-
ed insurmountable challenges. First, the starting δ-keto-aldehyde was difficult to prepare: 
the PMB group could not be reliably brought through the ozonolysis step because ozone 
evidently reacts competitively between the olefin and PMB. Further, switching to a TES 
group only provided moderate relief, as the δ-keto-aldehyde was still prone to cycliza-
tion. Second, the Wittig reaction was difficult to scale: the reaction required cryogenic 
temperatures and always afforded variable amounts of the terminal epoxide (Scheme 
3.17).23–25 Third, the Z:E ratio was at best around 10:1, which would have been accepta-
ble save for the fact that the isomers were completely inseparable. 
Scheme 3.17: Wittig Reaction and Terminal Epoxide Byproduct  
 
These concerns, especially the instability of the δ-keto-aldehyde intermediate, ultimately 
led us abandon the Wittig as a scalable reaction and re-evaluate the other methods for cis-
diene installation. In particular, we hoped that we could employ the NHK/Peterson meth-
od because we knew from Novartis' 60-gram Discodermolide campaign22 that this reac-
tion sequence would be eminently scalable. Accordingly, we protected the ketone of the 
δ-keto-aldehyde that we believed to be the source of our initial NHK failure (Scheme 
3.18). 
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2. 2nd Generation C18-C25 Fragment Synthesis:e While the new dioxolane-containing 
target could, in principle, be obtained by optimizing the EZ-Mix crotylation reaction out-
lined in Scheme 3.15, we felt that realizing a substrate-controlled reaction would be more 
ideal. Consistent with prior art,26,27 treatment of our branched aldehyde with the achiral 
crotylboron pinacol reagent delivered the desired Felkin product in quantitative yield and 
as a single diastereomer (Scheme 3.19). 
Scheme 3.19: Screening of Crotylation Reagents for the C20-C22 Stereotriad 
 
 
With this crotylation reaction secured, Mr. Bucher then re-evaluated the NHK / Peterson 
sequence. With the problematic ketone functionality now protected, the desired cis-diene 
was obtained in good yield (65%) and as a single isomer (Scheme 3.20). Alas, the ketal 
could not be hydrolyzed without removing the C21 TES ether. Thus, an HCl quench of 
the Peterson olefination was employed to simultaneously remove both protecting groups 
and in a separate step, the C21 alcohol was re-protected. Routine hydrazone formation28 
then delivered the fully functionalized C18-C26 synthon. 
  
                                                      
























This 2nd generation route was significantly more scalable than the first, and Mr. Bucher 
prepared more than 21 grams of hydrazone C18-C26 in less than 2 weeks time. However, 
as the projected route to Dictyostatin continued to gain experimental validation, we want-
ed to improve two aspects regarding this fragment synthesis: (1) 4 eq. of chromium di-
chloride were required in the NHK; and (2) the C21 alcohol had to be twice protected. 
Scheme 3.20: 2nd Generation C18-C25 Fragment Synthesis 
 
To address these two TES protections, Mr. Bucher attempted the NHK / Peterson with a 
free C21 alcohol (Scheme 3.21 Top). While this sequence consistently provided product 
in good yield on small-scale (63%, 100 mg), elimination of the β-hydroxy-aldehyde was 
observed upon scale-up (38%, 600 mg). We do not understand why this occurred but note 
that it may be related to the heterogeneity of the NHK; evidently, our substrate is incom-
patible with the basic organochromium species. 
As for avoiding stoichiometric amounts of chromium, initial forays into a catalyt-
ic NHK using Fürstner's protocol (Mn, TMSCl) were unsuccessful.29,30 Though improved 
catalytic methods have been developed by others,31 Mr. Bucher decided to first seek an 




























































Scheme 3.21: Comparison of Dienylation Reactions with the C21 Free Alcohol. 
 
Here, with the Lewis acidic boron reagent, there is no base to promote elimination, and 
the boron reagent obviates the need for any chromium, even catalytic amounts. Further, 
Mr. Bucher found that he could run the allylation reaction at room temperature instead of 
at the cryogenic temperatures (-78 °C) employed in the original publication.f In practice, 
this Matteson reaction was simply quenched with KOH to induce a Peterson olefination, 
and when that was completed, HCl was added to hydrolyze the ketal. The one-pot trans-
formation afforded the cis-diene product in 71% yield and as a single isomer. 
In the final route (Scheme 3.22), a 4-step synthesis of hydrazone C18-C26 was 
achieved. It features (1) a one-pot hydroformylation / crotylation sequence; (2) a one-pot 
dienylation; and (3) a one-pot TES protection / hydrazone formation. 
Scheme 3.22: A 4-Step Synthesis of Hydrazone C18-C26 
 
                                                      
f We suspect that these cryogenic temperatures dissuaded Novartis from adopting the Matteson protocol. Of 
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V. Fragment Coupling 1: Hydrazone-Iodide Alkylation 
 
Before I discuss the hydrazone-iodide alkylation, note that we considered more than half 
a dozen other reactions to unite these two halves. Most never got off the ground as model 
studies failed; others were attempted on the real systems but found to be either low yield-
ing or some downstream reaction failed.g In Scheme 3.23, I provide a flavor for some of 
these attempts but will not discuss them further. 
Returning to the alkylation reaction diagrammed above, model studies identified 
the best coupling partners: both the hydrazone (vs. ketone) and iodide (vs. tosylate) were 
necessary for a productive reaction. Additionally, the additive DMPU, together with a Li 
counterion, was needed; Na and K bases simply resulted in iodide elimination. 
When the lithium base was n-butyl-lithium, a moderate yield (~50%) of the keto-
alcohol coupling adduct was obtained upon deprotection (Scheme 3.24A). Inspection of 
the crude material revealed two side-products amounting to the remaining mass balance. 
Evidently, n-butyl-lithium added into the cis-diene to form a lithium-allyl complex, some 
of which underwent a Brook rearrangement while the remainder attacked the iodide to 
form doubly alkylated product. 
With the non-nucleophilic base LDA (generated under hexane-free conditions for 
quantitative metalation),32 the two side-products were not observed, and the desired keto-
alcohol was isolated in yields ~20% higher (Scheme 3.24B). 
                                                      
g Many of these coupling strategies feature a lactone as the "hydrazone" fragment. This represents an early 











































































































































































































































































Scheme 3.24: Hydrazone-Iodide Alkylation using (A) n-BuLi or (B) LDA 
 
 
Post-fragment coupling, three transformations were needed to complete a fully functional 
C11-C26 synthon (Scheme 3.25A): (1) C19 ketone reduction; (2) C19 and C21 hydroxyl 
protections; and (3) C11 acetal deprotection. For transformation (1), syn-reduction of the 
C19 ketone was readily accomplished via a Prasad-modified Narasaka reduction (Scheme 
3.25B).33,34 
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Acetal deprotection proved difficult under Brønsted (PPTS, CSA, AcOH, HCl) and Lew-
is acidic (PdCl2, SnCl2) conditions. Either there was no reaction or the resultant aldehyde 
underwent enolization/elimination.h After more persistence, we found a report describing 
the use of TMS-OTf and 2,6-lutidine to deprotect acetals (Scheme 3.26).35 Here, the ini-
tially formed oxocarbenium ion is trapped by lutidine as the N,O-acetal, thus protecting 
the incipient aldehyde from decomposition. Upon quenching with water, the N,O-acetal 
is hydrolyzed under mild conditions. 
 
Scheme 3.26: Mechanism of TMS-OTf/Lutidine Mediated Acetal Hydrolysis 
 
  
                                                      
h Acetals exhibit completely different reactivity than ketals, which readily undergo hydrolysis with mild 
acid. This is because hydrogen (unlike carbon) is unable to support the rising positive charge that develops 






































An attractive implication about using TMS-OTf to trigger acetal deprotection is that silyl 
triflates are obviously compatible. Therefore, the C19 and C21 hydroxyls can be protect-
ed with silyl groups in the same pot (Scheme 3.27). 
 
Scheme 3.27: Completion of the C11-C26 Synthon 
 
 
Selective silylation of the less hindered C19 hydroxyl was performed (TBS and TIPS, for 
reasons to be described in Scheme 3.41), followed by TMS protection of the C21 hy-
droxyl (this site must be selectively deprotected for macrolactonization). In a single step, 
then, two alcohols are differentially protected and an aldehyde is revealed. The completed 
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VI. Phosphonate C1-C10  
Synthesis Plan: We planned to install the C10-C11 cis-olefin through a Still-Gennari Z-
modified Horner-Wadsworth-Emmons (HWE) olefination (Scheme 3.28). Therefore, the 
C1-C10 fragment was required to have a keto-phosphonate functional group, the specific 
identify of which will be discussed below (Figure 3.1). Further, the C1-C10 fragment ex-
hibits the outlines of a crotylation reaction (highlighted in red). The question was how to 
turn the crotylation adduct – and whatever synthetic handles there may be – into the nec-
essary terminal functionalities, i.e. the keto-phosphonate and cis-dienoate. 
Scheme 3.28: Synthesis Plan for Dictyostatin 
 
At the outset, this Still-Gennari bond construction was presumed to be a delicate exercise 
because the reacting carbon, instead of engaging intermolecularly as desired, could react 
intramolecularly in a conjugate addition (Scheme 3.29). Still, we felt that the reactivity of 
the phosphonate could potentially be tuned by changing counterions and solvent. 






















































1. Keto-Phosphonate: To the best of our knowledge, there have been no systematic stud-
ies on the syntheses of Z-unsaturated ketones via HWE olefinations. Therefore, we turned 
to the literature on Z-unsaturated esters. For this purpose, two types of phosphonates have 
been advanced (Figure 3.1). Still developed trifluoroethyl (TFE) phosphonates36 and An-
do disclosed aryl phosphonates.37–39 Both feature electron-withdrawing substituents at-
tached to phosphorus – pKa phenol = 18, DMSO; pKa TFE = 23.5, DMSO – which are 
believed to be responsible for Z-selectivity. However, there have been no computational 
studies on the intimate details of an HWE, and in particular, the role of the base and its 
counterion. 
 
Figure 3.1: Carboxy-Phosphonates for Z-Selective Horner Wadsworth Emmons 
We initially assumed that the reactivity profile of carboxy-phosphonates would transfer 
to a ketonic setting. However, for reasons unclear, the phenyl keto-phosphonate failed to 
deliver high Z-selectivity in model olefination studies (Scheme 3.30).i Thus, we turned to 
the TFE keto-phosphonate, having as our guide a few relevant reports: Paterson's Dicty-
ostatin40 and Discodermolide41,42 syntheses and a dissertation from the Maier group.43 
Scheme 3.30: Ando Phosphonate Model Olefination Studies 
 
                                                      














(A) NaI, DBU, THF: slow rxn
(B) NaI, DBU, MeCN: 2:1 Z:E
(C) Triton B, THF: β elimination
(D) NaH, THF: 2:1 Z:E





























First, though, we had to develop a practical method for synthesizing complex TFE keto-
phosphonates. The traditional method for making keto-phosphonates (R = EDG, i.e. Me) 
is via acylation of the methylphosphonate anion (Scheme 3.31A). With the TFE variant, 
however, this metallation is impractical because it must be performed at -100 °C (the ani-
on is unstable at -78 °C),44 and the acylation must be with an acid chloride. In our hands, 
this cryogenic reaction was nearly impossible to perform, and only low yields (35%) of 
the desired TFE keto-phosphonate could be obtained (Scheme 3.31B). The only other iso-
lable product was the enone derived from β-elimination. We surmise that the poor yield is 
due to the combination of (a) the difficulty in preparing the water-sensitive acid chloride 
and (b) the instability of the phosphonate anion to exotherms that arose during deprotona-
tion. Thus, a more practical method had to be developed. 
 








































Recourse lay in our initial attempts to probe the Ando HWE (Scheme 3.30). In preparing 
the requisite phenyl keto-phosphonate, we were surprised to discover that P(OMe)(OPh)2 
productively engaged an α-bromoketone in an Arbuzov reaction (Scheme 3.32A). Excel-
lent yields were obtained and contrary to literature expectation, Perkow rearrangement to 
the enol phosphonate was not observed.45 Surprisingly, however, the corresponding Ar-
buzov reaction with either P(OTFE)3 or P(OMe)(OTFE)2 only resulted in decomposition. 
To rationalize this difference in reactivity, consider that the Arbuzov reaction oc-
curs via a two-step process: initial halide displacement to afford a phosphonium salt, fol-
lowed by dealkylation and phosphonate formation (Scheme 3.32C). To the extent that 
TFE is less electron-withdrawing than Ph (as reflected in their pKa values: phenol = 18, 
DMSO; TFE = 23.5, DMSO), the second step of this process is slowed down in the case 
of P(OMe)(OTFE)2. Evidently, this gives the phosphonium intermediate extra time to de-
compose. 
Scheme 3.32: Arbuzov Reaction toward (A) Ando and (B) Still Keto-Phosphonates; 






























































Nonetheless, given the successful Arbuzov toward the phenyl phosphonate, Mr. Bucher 
wondered whether he could transesterify the product with TFE to arrive at the TFE phos-
phonate (Scheme 3.32B). Indeed, this idea was put into practice using DBU in a 2:1 mix-
ture of TFE and THF (THF accelerated the SN2 reaction). Further, the Arbuzov and trans-
esterification reactions can be combined as a 1-pot procedure and performed on decagram 
scale. 
During the trans-esterification step, a small amount (<10%) of de-brominated me-
thyl ketone was typically formed (Scheme 3.33). To the extent that leaving group ability 
tracks with pKa, it is worth noting that the pKa of acetone enol (10.9, H2O) is comparable 
to that of phenol (10, H2O). Thus, Mr. Bucher tried to optimize the trans-esterification by 
screening aryl phosphites, the logic being that more strained or electron-withdrawing aryl 
groups would show greater leaving group ability. In practice, however, many of these de-
signer phosphites were unreactive in the Arbuzov and even then, uncompetitively against 
the commercially available P(OMe)(OPh)2. 













































In securing the preceding Arbuzov / trans-esterification procedure, we identified a critical 
bromoketone intermediate that clarified our overall C1-C10 synthesis plan (Scheme 
3.28). It indicated that we engineer a crotylation reaction such that the resulting adduct 
could directly be brominated. As outlined in Scheme 3.34, we eventually prepared this 
bromoketone in two steps from commercially available material. Application of our cro-
tylation methodology delivered a methyl ketone bearing the C6 and C7 stereocenters. 
Bromination of this methyl ketone then occurred via in situ NBS treatment of the silyl 
enol ether. Conversion to the keto-phosphonate (vide supra) then set the stage for instal-
lation of the cis-dienoate. 















































2. cis-Dienoate: There were two questions to be answered: (1) how to install the dienoate 
and (2) what would be the C1 protecting group. Regarding question (1), several strategies 
from prior art involved pre-activation of the terminal olefin; for example, (a) oxidative 
cleavage / Takai olefination to afford a vinyl iodide for cross-coupling;40 or (b) oxidative 
cleavage / Corey-Fuchs / hydroboration to afford a vinyl boronate for cross-coupling.46,47 
The only direct route to the dienoate was an ene-diene cross-metathesis reported 
by Curran (Scheme 3.35A).48 However, in our hands, this reaction could not be repro-
duced; only diene polymerization was observed. Curran also reported a stepwise proce-
dure that involved a metathesis / Still-Gennari sequence (Scheme 3.35B).49 Notably, this 
would not require prior activation of the olefin but we found that, while the metathesis 
successfully afforded aldehyde, the Still-Gennari could not be performed in the presence 
of the β-keto-phosphonate already present in the substrate. It is possible that the more 
basic carboxy-phosphonate deprotonates the keto-phosphonate, which subsequently un-
dergoes conjugate addition into the unsaturated aldehyde, as outlined in Scheme 3.29. 
Therefore, a new tactic had to be developed, and we were committed to it being a one-
step procedure. 














































We found inspiration from sporadic reports50–52 on a Heck reaction toward cis-dienoates 
but at the outset, we were uncertain whether our β-keto-phosphonate would be compati-
ble with the basic conditions of a Heck. After extensive screening, however, the desired 
cis-dienoate was obtained in excellent yield and isomeric purity, on gram-scale (Scheme 
3.36). A methyl ester was initially chosen as the C1 protecting group, although as will be 
discussed below, we were unaware of the challenges to be met with this group. Pd(OAc)2 
was used under ligand-free conditions,j with a stoichiometric amount of silver carbonate. 
Scheme 3.36: Heck Reaction Toward the C2-C25 cis-Dienoate 
 
Two aspects of this reaction bear further comment: 
Ligand-Free: Because the reaction is run under ligand-free conditions, one can speculate 
whether it is mediated by the formation of palladium nanoparticles.53–55 Indirect support 
for this proposal include the presence of a variable induction period, followed by a kinet-
ic burst, and the observation of a cloudy red solution and the formation of palladium 
black. Further, strong acids (i.e. HI) and solvents of high dielectric constants (i.e. MeCN) 
are known to catalyze the formation and/or stabilization of palladium nanoparticles. 
Silver Base: A silver base was used to minimize dienoate isomerization via reversible β-
hydride elimination.56 Further, the base is visibly insoluble in MeCN (which may be the 
reason for negligible keto-phosphonate deprotonation) but can still abstract iodide from 
the palladium complex formed upon oxidative addition and neutralize the acid formed 
during the reaction. 
                                                      






















VII. Fragment Coupling 2: Z-selective HWE olefination 
With a scalable 4-step synthesis of the C1-C10 phosphonate in hand, we began to model 
the Still-Gennari HWE olefination (Scheme 3.37). Initial studies were performed with 
sodium hydride as the base, and good Z:E selectivity (5:1 Z:E) and yields (70% Z) were 
obtained. Importantly, the phosphonate did not react with itself (through a conjugate ad-
dition into the dienoate) and the cis-dienoate remained intact (no ε deprotonation), estab-
lishing this HWE bond construction as a viable coupling strategy. 
 
Scheme 3.37: Still-Gennari HWE Olefination Model Studies 
 
 
However, in attempts to hydrolyze the methyl ester for macrolactonization, we discov-
ered that under standard basic conditions, competitive deprotonation / decomposition of 
the cis-enone occurred. Further, methods57,58 that have been touted as "milder" alterna-
tives to basic hydrolysis simply resulted in no reaction. In hindsight, this methyl ester was 
clearly the wrong protecting group, and moving forward, we needed an ester that could 






























(C) Me3Sn-OH, DCE, 80oC






Recall that the ester was introduced via an iodoacrylate in a Heck reaction (Scheme 3.36). 
Thus, several acrylates were screened in this coupling (Scheme 3.38). In principle, a tBu 
ester can be removed with acid and silyl esters with fluoride, either of which is compati-
ble with the base-sensitive cis-enone. However, it turned out that only the Me and TMSE 
acrylates successfully gave product in the Heck. The others simply returned starting ma-
terial, suggesting that steric effects form the basis for the lack of reactivity. 
Scheme 3.38: Screen of Iodo-Acrylates for the Heck Reaction 
 
With confidence from our model HWE studies, we tested this new TMSE-containing C1-
C10 phosphonate with the fully functionalized C11-C26 fragment (Scheme 3.39). Fortu-
nately, a consistent 5:1 Z:E ratio was obtained, indicating the ester substituent played no 
role during the C10-C11 bond construction.k 
Scheme 3.39: Still-Gennari HWE Olefination using NaH 
 
                                                      






































































To deprotect the TMSE ester, we employed a mild, hypervalent source of fluoride: TAS-
F.59 Unexpectedly, however, both the TMSE ester and C19 TBS ether were competitively 
cleaved, such that 1 equiv of TAS-F resulted in a mixture of products (Scheme 3.40). Ex-
cess TAS-F cleanly delivered the C19, C21 diol / C1 acid but attempted macrolactoniza-
tion of this substrate showed no conformational preference for the desired 22-membered 
lactone corresponding to cyclization of the C21 hydroxyl. The desired product and ring-
contracted macrolactone were generated in roughly equimolar amounts.l 
Scheme 3.40: TAS-F Treatment with a C19 TBS Protecting Group 
 
Based on prior art,59 TBS protected 2° alcohols should be stable to TAS-F. With our sub-
strate then, the C21 OH is likely hydrogen-bonding to the C19 oxygen and weakening the 
O-Si bond. Thus, the TBS group was replaced with the more stable TIPS (Scheme 3.27) 
and with this modification, the TMSE ester could be selectively removed provided one 
equiv. of TAS-F was employed; excess still resulted in TIPS deprotection (Scheme 3.42). 
Finally, we had secured our protecting group strategy: TBS at C7 and C11; TIPS at C19. 
                                                      
l We did not determine whether this product ratio reflects a kinetic or thermodynamic distribution. Howev-














































































DMAP (1 eq), NEt3 (10 eq.)
Toluene (0.001M)
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Having committed to our coupling partners and their protecting groups, we stood ready to 
optimize the HWE fragment coupling. First, we wanted to improve the 5:1 Z:E ratio, po-
tentially by changing the counterion of the base. Second, the yield for the HWE was ra-
ther variable (0-70%), and we sought a more reproducible reaction. 
For the latter issue, we attributed the variability to having excess base in the reac-
tion (which can destroy the aldehyde via β-elimination), either because of the variable 
quality of NaH or the difficulty in accurately weighing out small quantities of it. Further, 
adventitious water is known to quench NaH and generate highly reactive anhydrous hy-
droxide, which can cleave the TMSE ester and deprotonate the aldehyde.60 To obtain 
more precision, we decided to substitute NaH for NaHMDS, which can be conveniently 
employed as a 1 M THF solution.m This NaHMDS procedure has since been performed 
many times and always, the (Z)-adduct can be isolated in >70% yield (5:1 Z:E). Further, 
using HMDS bases allowed ready screening of the counterion; unfortunately, neither Li 
nor K provided a better isomeric ratio (Scheme 3.41).n 
Scheme 3.41: Still-Gennari HWE Olefination using NaHMDS 
 
                                                      
m For a 100 mg scale reaction, this modification means that one is measuring out hundreds of microliters of 
NaHMDS instead of milligram amounts of NaH, 
n For comparison, the classical Still-Gennari conditions are KHMDS/18c6.36 For Ando HWEs, K bases are 






































with KHMDS: 1.8:1 Z:E
with KHMDS/18c6: β-elim. of aldehyde
with NaHMDS: 5:1 Z:E
with LiHMDS: 1:1 Z:E
Counterion Screen
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VIII. Completion of the Synthesis of Dictyostatin 
1. Macrolactonization: After TASF deprotection, the resulting acid could be isolated but 
it was easier to subject the crude material directly to macrolactonization (Scheme 3.42). 
We did not want to tempt its stability on silica gel, especially on larger scale, and it did 
not appear that the lactonization was affected by the use of crude material. We used the 
Shiina reagent (instead of Yamaguchi) to minimize isomerization of the (Z,E)-dienoate.61 
The desired macrolactone was isolated in a 61% yield over 2 steps. 
Scheme 3.42: TMSE Deprotection and Shiina Macrolactonization 
 
 
2. C9 Enone Reduction: The final obstacle to Dictyostatin was setting the C9 stereocen-
ter. We had planned to use a Luche reduction reported by Paterson that exploits the mac-
rocyclic conformation of Dictyostatin for stereocontrol.62,63 However, a single reduction 
attempt resulted in the undesired C9 diastereomer as the major product (Scheme 3.43). 
Initially, the different C19 silyl groups (TBS vs. TIPS) were thought to be the source for 
this discrepancy but we prepared the identical C19 TBS substrate (via the non-selective 
macrolactonization in Scheme 3.37) and still, the diastereoselectivity fell short of what 
Paterson had reported. Evidently, this Luche reduction is a capricious reaction.o 
                                                      
o In Paterson's 2nd generation synthesis of Dictyostatin,40 this Luche reduction was replaced by a CBS re-
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Scheme 3.43: Comparison of Luche Reductions 
 
To rely on a late-stage and high-risk reduction, Paterson performed a Monte-Carlo search 
using molecular mechanics to identify low-energy conformations of the cis-enone, all of 
which showed its bottom face shielded by the bulky C7 TBS group. In this logic, the hy-
dride should approach from the top face, giving the correct C9 diastereomer. However, 
there are 2 issues with this logic. First, regarding the computations, was it implemented 
with high-level theory?p The second is subtler: can one reliably predict the outcome of 
reactions on chiral macrocycles by considering only their ground state conformations? 
Such a peripheral attack model has a 30-year history dating back to Still64 and has 
been widely adopted as a basis for using macrocycles as stereocontrol elements. Howev-
er, a recent retrospective study by Evans65 indicates that this model is "fraught with too 
many compromising assumptions." Implicit is that low-energy ground states (as opposed 
to transition states) are the most reactive ones and that other factors including the reaction 
types and reaction conditions can be ignored. This is a simplification that, according to 
Evans' study, only holds true in limited, metal-freeq reactions. 
                                                      
p The Evans Group performed a Monte-Carlo Multiple Minimum search using molecular mechanics (MM) 
and MM in conjunction with density functional theory (DFT).65 They observed a poor correlation between 
MM and DFT energies. Further, the MM-DFT search located ambiguous local minima (that exposed both 
faces of the enone to reduction) and incorrect minima (that exposed the incorrect face of the enone. 
q It is unlikely that CeCl3 is acting as a chelating Lewis acid with silyloxy substituents.88,89 However, such a 
role would obviously confound any conformational analysis based on ground state structures. Further, see 
Nicolaou's synthesis of Monorhizopodin for an example in which the diastereoselectivity of a sodium boro-
hydride reduction is significantly affected by the addition of Ce(III).90 
cf. Paterson 2004: R = TBS, 70% yield































Returning to our C9 stereocenter problem, additional data points from achiral reductions 
(including with an acyclic substrate) indicate that the intrinsic pi-facial bias of the enone 
favors the undesired isomer (Scheme 3.44). Paterson's results notwithstanding, our results 
suggest that there are local interactions at play that resist reduction to the 1,3-anti prod-
uct.r Therefore, we surveyed methods for reagent-controlled carbonyl reduction, as de-
picted in Scheme 3.44.66–68 
Scheme 3.44: Screening C9 Enone Reduction Conditions 
 
                                                      
r Paterson has reported that an Evans-Saksena91,92 directed reduction, which is textbook for delivering high 
1,3-anti selectivities, afforded only a 2:1 dr of the desired isomer. Interestingly, reduction of the C10-C11 
saturated compound resulted in the desired C9 isomer in a 10:1 dr.93 
Achiral Hydride Sources
NaBH4, CeCl3, EtOH 1:3 dr
< 1:10 drLiAlH(OtBu)3, Tol
decomp
decompNaBH(sBu)3, Tol
(R)-CBS / BH3-THF / THF / RT 2:1 dr
(S)-CBS / BH3-THF / THF / RT < 1:10 dr
< 1:10 dr
(S)-Alpine Hydride, THF






































































(R)-CBS / HBCat / Tol / -20oC > 10:1 dr






Our first lead came from an (R)-oxazaborolidine-mediated BH3 reduction, carried out in 
THF at room temperature, which afforded a 2:1 ratio of diastereomers but with numerous 
side-products. To improve selectivity, we sought to lower the reaction temperature but at 
0 °C, no reaction occurred. Hypothesizing that THF was coordinatively saturating the 
borane, we changed solvents to the non-coordinating Toluene and borohydride source to 
catecholborane, thereby allowing reaction to occur at -78 °C. With these modifications, 
clean conversion to product was observed and importantly, with >10:1 dr (Scheme 3.45). 
Scheme 3.45: C9 Enone CBS Reduction 
 
Global deprotection: The last step of the route was to deprotect the three silyl protecting 
groups (Scheme 3.46). We found that HF-pyridine was superior to HF/MeCN/H2O and 
that ring-contraction to the 20-membered macrocycle was minimal. 6 mg of Dictyostatin 
were ultimately prepared, and the remainder of our material was used to support the ana-
log development that will be the topic of Chapter 4. 


































































Described in this chapter is a short and modular synthesis of Dictyostatin that is 14 steps 
in the longest linear sequence (summarized in Scheme 3.47). The high efficiency is prin-
cipally due to application of the Landis hydroformylation and our crotylsilane platform. 
These methods facilitated the syntheses of adducts containing multiple, contiguous stere-
ocenters with useful handles for further functionalization. The significance of this is that 
we were able to stockpile decagram amounts of the three modular components, each pre-
pared in 4-5 steps in 2-3 weeks, which is enabling the conjugation studies that will be de-
scribed in Chapter 4. 
Of course, it is of no use to have efficient fragment syntheses if the fragments 
cannot be coupled. In this regard, we have identified a new method for preparing com-
plex Ando and Still-type keto-phosphonates. Easier access to these phosphonates should 
render the HWE strategy toward cis-enones a more viable option in retrosynthetic plan-
ning. When combined with a CBS reduction, complex cis-allylic alcohols can also be ac-
cessed. Thus, not only have we synthesized Dictyostatin, we have developed strategies 
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X. Supporting Information 
Experimental Procedures: Most compounds in Chapter 4 have been previously charac-
terized and reported in our Dictyostatin communication.1 Select unpublished compounds 
are included herein. 
Compounds from IV. Hydrazone C18-C25 
 
To a cooled (-78 °C) solution of alcohol (3.7 g, 24 mmol, 1 equiv) in CH2Cl2 (120 mL, 
0.2 M) was added 2,6-lutidine (5.5 mL, 47 mmol, 2 equiv) and TES-OTf (5.9 mL, 26 
mmol, 1.1 equiv). After 1h, the reaction mixture was quenched with saturated aqueous 
NH4Cl (50 mL). The aqueous layer was separated and extracted with CH2Cl2. The com-
bined organic layers were dried over MgSO4, filtered, and concentrated. Purification was 
accomplished by silica gel flash column chromatography (2% EtOAc/Hex) affording 
TES ether (6.3g, 97% yield) as a colorless oil. TLC Rf = 0.57 (10% EtOAc/Hex); IR 
(thin film) 2959, 2878, 1713, 1459, 1114, 1053, 1006, 739 cm-1; [α]21D 2.3 (c = 1.0, 
CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 5.80 (ddd, J = 17.1, 10.4, 8.1 Hz, 1H, C23H), 
5.03 – 4.95 (m, 2H, C24H2), 3.91 (dd, J = 7.1, 3.6 Hz, 1H, C21H), 2.66 (p, J = 7.1 Hz, 1H, 
C20H), 2.28 – 2.19 (m, 1H, C22H), 2.13 (s, 3H, C18H3), 1.10 (d, J = 7.1 Hz, 3H), 1.02 (d, J 
= 6.9 Hz, 3H), 0.97 (t, J = 7.9 Hz, 9H, TES), 0.63 (q, J = 7.9 Hz, 6H, TES); 13C NMR 
(100 MHz, CDCl3) δ 212.1, 140.5, 115.3, 76.7, 51.1, 43.3, 30.0, 17.2, 13.8, 7.2, 5.6; 












Ozonolysis: To a cooled (-78 °C) solution of olefin (1.5g, 5.5 mmol, 1 equiv) in CH2Cl2 
(55 mL, 0.1 M) was bubbled in ozone. After the solution turned blue, the mixture was 
purged with oxygen until colorless. PPh3 (1.5g, 5.8 mmol, 1.1 equiv) was added, and the 
reaction mixture was allowed to warm to room temperature. After 16h, the reaction mix-
ture was concentrated, triturated with hexanes (3x50 mL) to remove Ph3P=O, and azeo-
troped with benzene (3x50 mL). The crude aldehyde was used immediately without fur-
ther purification. Wittig: To a solution of phosphonium salt (4.4 g, 8.3 mmol, 1.5 equiv) 
in THF (55 mL, 0.1 M) was added NaHMDS (1M THF, 8.3 mL, 8.3 mmol, 1.5 equiv) 
dropwise. After 20 min, the reaction mixture was cooled to -78 °C, and a solution of al-
dehyde in THF (5 mL) was added. The reaction mixture was stirred at -78 °C for 1h and 
then allowed to warm to 0 °C over 1h as the dry ice bath expired. The reaction mixture 
was quenched with saturated aqueous NH4Cl (0.1 mL), diluted with hexanes to precipi-
tate Ph3P=O, and filtered over a pH 7.0 buffered silica gel plug, eluting with 10% 
EtOAc/Hex (250 mL). The filtrate was concentrated and directly purified by pH 7.0 buff-
ered silica gel flash column chromatography (5% EtOAc/Hex) affording vinyl iodide 
(1.54 g, ~8:1 Z:E, 70% yield) as a yellow oil, which was contaminated with a small 
amount of phosphine impurities. The vinyl iodide was used immediately without further 
purification. 1H NMR (400 MHz, CDCl3) δ 6.28 – 6.23 (m, 2H, C23H, C24H), 4.00 (dd, J 
= 7.8, 2.6 Hz, 1H, C21H), 2.68 – 2.60 (m, 1H, C20H), 2.59 – 2.52 (m, 1H, C22H), 2.20 (s, 
3H, C18H3), 1.13 (d, J = 7.1 Hz, 3H), 1.03 (d, J = 7.0 Hz, 3H), 0.99 (t, J = 8.0 Hz, 9H, 
TES), 0.67 (q, J = 8.0 Hz, 6H, TES); 13C NMR (125 MHz, CDCl3) δ 211.9, 142.8, 128.5, 



















To a solution of vinyl iodide (1.4 g, ~8:1 Z:E, 0.35 mmol, 1 equiv) and tributyl(vinyl)tin 
(1.5 mL, 5.3 mmol, 1.5 equiv) in DMF (35 mL, 0.1M) was added PdCl2(MeCN)2 (92 mg, 
0.35 mmol, 10 mol%). After 4h, the reaction mixture was quenched with saturated aque-
ous NaCl. The aqueous layer was separated and extracted with 20% EtOAc/Hex. The 
combined organic layers were dried over Na2SO4, filtered, and concentrated. Purification 
was accomplished by pH 7.0 buffered silica gel flash column chromatography (5% 
EtOAc/Hex) affording cis-diene (1.1 g, ~8:1 Z:E, 95% yield). TLC Rf = 0.60 (10% 
EtOAc/Hex); [α]21D 18.2 (c = 1.0, CH2Cl2); IR (thin film) 2959, 2877, 1713, 1459, 1239, 
1119, 1077, 1054, 1008, 738 cm-1; 1H NMR (400 MHz, CDCl3) δ 6.47 (dt, J = 16.8, 10.6 
Hz, 1H, C25H), 6.02 (t, J = 10.9 Hz, 1H, C24H), 5.49 (t, J = 10.3 Hz, 1H, C23H), 5.20 (d, J 
= 16.8 Hz, 1H, C26Ha), 5.09 (d, J = 10.2 Hz, 1H, C26Hb), 3.90 (dd, J = 7.6, 3.2 Hz, 1H, 
C21H), 2.74 – 2.60 (m, 2H, C22H, C20H), 2.10 (s, 3H, C18H3), 1.10 (d, J = 7.1 Hz, 3H), 
1.01 (d, J = 6.9 Hz, 3H), 0.97 (t, J = 8.0 Hz, 9H, TES), 0.63 (q, J = 8.0 Hz, 6H, TES); 13C 
NMR (100 MHz, CDCl3) δ 212.4, 134.0, 132.4, 129.8, 117.8, 51.8, 36.9, 30.1, 18.9, 14.1, 

















β-hydroxy-silane from NHK reaction: 1H NMR (500 MHz, CDCl3) δ 5.86 (dt, J = 17.1, 
10.3 Hz, 1H, C25H), 5.01 (dd, J = 10.3, 2.2 Hz, 1H, C26Ha), 4.93 (ddd, J = 17.1, 2.2, 0.9 
Hz, 1H, C26Hb), 3.99 – 3.96 (m, 2H, C21H, C23H), 3.96 – 3.93 (m, 2H), 3.91 – 3.85 (m, 
2H), 2.55 (d, J = 2.7 Hz, 1H, OH), 1.97 (dd, J = 10.3, 6.3 Hz, 1H, C24H), 1.91 (qd, J = 
7.1, 3.2 Hz, 1H, C20H), 1.76 (app. qt, J = 6.9, 3.8 Hz, 1H, C22H), 1.25 (s, 3H, C18H3), 
1.01 (d, J = 7.1 Hz, 3H, C20CH3), 1.00 (d, J = 6.9 Hz, 3H, C22CH3), 0.96 (t, J = 8.0 Hz, 
9H, TES), 0.64 (q, J = 8.0 Hz, 6H, TES), 0.03 (s, 9H, TMS); 13C NMR (125 MHz, 
CDCl3) δ 137.3, 114.0, 112.5, 74.5, 72.1, 64.5, 64.4, 44.5, 44.3, 40.8, 21.2, 11.8, 11.8, 
7.3, 5.4, -1.8. 
 
Compound from VI. Phosphonate C1-C10 
 
To a solution of phosphonate (200 mg, 0.4 mmol, 1 equiv) and vinyl iodide (127 mg, 0.6 
mmol, 1.5 equiv) in MeCN (2 mL, 0.2 M) was added Ag2CO3 (176 mg, 0.64 mmol, 1.6 
equiv) and Pd(OAc)2 (5 mg, 0.02 mmol, 5 mol%). Additional Pd(OAc)2 (5 mg) was add-
ed at t = 12h and t = 24h. After a total reaction time of 36h, the reaction mixture was di-
rectly purified by pH 7.0 buffered silica gel flash column chromatography (5-20% 
EtOAc/Hex) affording dienoate (150 mg, 64% yield) as a pale yellow oil. TLC Rf = 0.2 
(20% EtOAc/Hex); [α]20D -2.6 (c = 1.0, CH2Cl2); 1H NMR (500 MHz, CDCl3) δ 7.34 






























Hz, 1H, C5H), 5.62 (d, J = 11.3 Hz, 1H, C2H), 4.48 – 4.38 (m, 4H), 4.21 – 4.17 (m, 1H, 
C7H), 3.70 (s, 3H), 3.35 – 3.20 (m, 2H, C10H2), 2.67 (dd, J = 16.8, 6.9 Hz, 1H, C8Ha), 
2.57 (dd, J = 16.8, 5.0 Hz, 1H, C8Hb), 2.51 – 2.44 (m, 1H, C6H), 1.08 (d, J = 6.8 Hz, 3H, 
C6CH3), 0.86 (s, 9H, TBS), 0.08 (s, 3H, TBS), 0.01 (s, 3H, TBS); 13C NMR (125 MHz, 
CDCl3) δ 200.0 (d, 2JC,P = 7.0 Hz), 166.9, 145.4, 145.0, 127.7, 122.6 (q, 2JC,F = 277.9 
Hz), 122.6 (q, 2JC,F = 277.5 Hz), 116.4, 71.3, 62.5 (qd, J = 38.1, 5.2 Hz), 62.5 (qd, J = 
38.1, 5.2 Hz), 48.8 (d, 3JC,P = 5.1 Hz), 43.0, 42.8 (d, 1JC,P = 138.6 Hz), 25.9, 18.1, 15.0, -
4.6, -4.6; IR (thin film) 2931, 1716, 1639, 1597, 1258, 1174, 1072, 962, 836, 776 cm-1; 
HRMS: Exact mass calcd for C22H35F6NaO7PSi [M+Na]+: 607.1692; found 607.1692 
(FAB+).  
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I. Introduction 
As a direct result of our group's methodology and synthesis programs, we are in a unique 
position to access large quantities of some of the most potent anti-mitotic compounds yet 
discovered. Thus, an emerging goal in our group is to develop these natural products into 
clinical candidates for the treatment of cancer1,2 and neurodegeneration.3,4 In particular, 
Dictyostatin is a microtubule stabilizer with IC50 values in the low nanomolar range and a 
mechanism of action similar to the successful chemotherapeutic paclitaxel (Taxol).5 
However, systemic side-effects would likely preclude the usage of Dictyostatin in 
a standard chemotherapy regimen. In fact, toxicities are the reason why Discodermolide, 
a polyketide that is structurally similar to Dictyostatin, was suspended in Phase II trials.6 
To advance Dictyostatin into the clinic, a mechanism that enables targeted drug delivery 
to tumor cells will likely be required. 
 
With this objective in mind, we have become interested in conjugating Dictyostatin (and 
other small molecules) to targeted delivery vehicles, for example antibodies7–9 and viral 
capsids.10 Indeed, the FDA has recently approved two antibody-drug conjugates (ADCs) 
– Adcetris and Kadcyla – for oncological indication and notably, the warheads of both of 
these ADCs are microtubule-binding agents, like Dictyostatin. 
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II. General Considerations Regarding Linker Attachment 
Initial studies focused on how and where to attach a linker to Dictyostatin (DCT) without 
abolishing binding affinity and cytotoxicity. To answer the how question, we turned to 
the extensive bio-conjugation literature on azides. The basic logic is to attach an azide to 
Dictyostatin and then employ either (a) a traceless Staudinger11 or (b) azide-alkyne click 
reaction12,13 to conjugate Dictyostatin to a hypothetical delivery vehicle (Scheme 4.1).  
 
Scheme 4.1: Schematic for Dictyostatin (DCT) Conjugation to Antibody (mAb) 
 
 
Both of these reactions were considered to be highly reliable because of the stringent 
requirements that bio-orthogonal reactions must meet, particularly the ability to react 
rapidly at low concentrations and selectively in the presence of other functionality (high 
chemoselectivity).14 As an added advantage, azides are sterically small, synthetically easy 
to install, and inert to most chemical reaction conditions. Therefore, we can introduce the 
azide early in our Dictyostatin synthesis and be confident that it will survive until the 
required late-stage modification. The open questions were whether the linking amide or 
triazole functionality would (a) be tolerated at or near the microtubule-binding site and 
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To answer the where question, we analyzed the two models15,16 put forth in the literature 
for Dictyostatin binding in the taxane site of β-tubulin, described in detail in Appendix 2 
and depicted in Figure 4.1. 
     
Figure 4.1: Snyder (L) and Dı́az (R) Models for Dictyostatin Binding in β-Tubulin.16 
At this stage of analysis, the only criteria to be a candidate ligation site was that it be 
solvent-exposed in either one or both of the models; we considered them to be of equal 
quality. Four potential sites of linker attachment were identified: C9 OH, C6 Me, C12 
Me, C22 Me (Figure 4.2), but given the nature of our synthetic route (Scheme 3.47), we 
elected to first target linker attachments at C9 OH and C6 Me.  
 
Figure 4.2: Four Candidate Sites for Dictyostatin Linker Attachment 
More detail will be provided about each ligation site as this chapter unfolds but for the 
moment, we need only point out that of the four sites, one of them is an alcohol and three 
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Of course, alcohol acylation is a natural strategy for tagging molecules with a molecular 
handle. For example, both the FDA approved ADCs – Adcetris and Kadcyla – have their 
warheads conjugated through alcohols (or amines). However, acylation via DCT's C9-
OH presented problems (vide infra) that forced us to consider alternative ligation sites 
and therefore, alternative methods of tagging. 
 Despite a few recent reports describing conjugation via C-H activation reactions, 
tagging unactivated C-H bonds represents an underexplored arena.17,18 In particular, we 
became interested in methyl modification because, in principle, extending a methyl group 
into a longer alkyl chain should represent a minimal electronic and steric perturbation to 
Dictyostatin's overall conformation, in a way that perhaps alcohol acylation does not (i.e. 
hydrogen-bonding is unaffected). Yet, to the best of our knowledge, there are only two 
examples in the vast microtubule literature wherein a methyl group had been selected as a 
site of linker attachment: in Schreiber's Discodermolide studies19 and in Bayer-Schering's 
epothilone analog, sagopilone.20,21 Presumably, this is because methyl conjugation 
requires deep-seated structural modifications that only total synthesis can deliver. On the 
other hand, we have a total synthesis of Dictyostatin that is short and modular (14 steps in 
the longest linear sequence) and that therefore puts us in a unique position to investigate 
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III. C9-OH Dictyostatin Analogues 
First, the C9 hydroxyl. This was an obvious candidate site for linker attachment because: 
(1) both the Snyder and Dı́az models indicated that this site would be solvent-exposed; 
(2) Paterson had reported that the DCT C9-OMe analog retains activity; thus, the C9 
hydroxyl is likely not involved in critical hydrogen bonding (Figure 4.3);22,23 and (3) the 
C9 hydroxyl was simple to derivatize at a late-stage in the synthesis, by C9 acylation and 
global deprotection (Scheme 3.47). 
 
Figure 4.3: Paterson's IC50 Values for DCT and C9-OMe-DCT 
We quickly prepared the two C9 acyl analogues depicted in Figure 4.4 to probe whether 
C9 was in fact a solvent-exposed site.  
 
Figure 4.4: EC50 Values for C9 Analogues of DCT (Columbia Genome Center) 
The IC50 values obtained were consistent with this solvent-exposed interpretation but as 
we continued to gather additional data points (vide infra), it became evident that there 
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intracellular esterase proteins could be cleaving the C9 ester and releasing free 
Dictyostatin; additionally, the triazole group in the linker could be facilitating C9 
hydrolysis via general base catalysis. In either case, the IC50 values would correspond to 
Dictyostatin rather than the analogues.  
Further, in preparing the C9-acyl compounds, we observed a separate stability 
issue: the C9 acyl group can evidently migrate to the C7 hydroxyl (Scheme 4.2).a 
Scheme 4.2: DCT C9-C7 Transesterification 
 
 
Therefore, it is ambiguous whether the observed activity can be attributed to the C9-acyl 
compounds or if C9 hydrolysis and/or C9-C7 transesterification are confounding the data. 
These complications ultimately led us to table C9 as a candidate site for conjugation. We 
felt that it would be more ideal to conjugate Dictysotatin through a non-cleavable linker, 
and it was at this point that we turned to the C6 methyl ligation site. 
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IV. C6-Me Dictyostatin Analogues 
We sought to extend the C6 methyl group into a non-cleavable alkyl chain terminating in 
an azide, which could then be employed in a Staudinger or alkyne click reaction (Scheme 
4.3). This methyl modification should, in principle, not affect the overall conformation of 
DCT and also obviate the stability issues that confounded the DCT C9-OH data. Further, 
Curran had reported C6-epi-Dictyostatin to be among the most potent DCT analogs and 
selected it for the only in vivo studies reported to date.24 Thus, we had some level of 
confidence that the C6-Me was not at the ligand-protein interface, consistent with the 
Snyder model16 of Dictyostatin binding.  
Scheme 4.3: Retrosynthesis of the DCT C6-Azide Analog 
 
 
The synthesis of the DCT C6-azide analog was accomplished using a synthetic sequence 
similar to the parent compound (Scheme 4.4). The azide linker was readily introduced via 
a cross-metathesis/crotylation reaction, followed by chloride-to-azide exchange. The C1-
C10 synthon was prepared in 5 steps, and an additional 5 steps were required to reach the 
final target compound. 
 Two aspects about this reaction sequence bear further comment. First, the cross-
metathesis step afforded a mixture of E:Z isomers; thus, the crotylation adduct is formed 
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the diastereomers could be separated at the stage of the cis-dienoate. Second, the Still-
Gennari reaction afforded a 3:1 ratio of Z:E enones (quantitative yield). For comparison, 
in the parent series without the C6 azide linker, product was obtained in a higher 5:1 Z:E 
ratio. The cause for this reduction in selectivity is still under investigation. 
In the end, the bottom line is that the entire reaction sequence took approximately 
15 days. This is the power of our synthetic route: we can rapidly design and synthesize 
analogs bearing deep-seated structural modifications. 


















(1) TBS-OTf; NBS (78%)






















































































C6 diastereomers were separated at this stage
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The DCT C6-azide analog was then functionalized in two conjugation reactions: (1) a 
Staudinger ligation and (2) an azide-alkyne click reaction (Scheme 4.5). For the latter, we 
found that the copper-catalyzed variants promoted ring-contraction to the (biologically-
inactive) 20-membered lactone. Thus, we adopted the copper-free variant using strained 
cyclooctynes.13 
Scheme 4.5: DCT C6-Azide Ligation Reactions: (A) Traceless Staudinger Ligation; 
(B) Copper-Catalyzed Click; (C) Copper-Free Click 
 
 
On the whole, the azide-cyclooctyne click was exceptionally reliable: clean and complete 
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with DCT remaining; unidentifiable compounds related to DCT were observed; and the 
phosphine thiol tended to oxidize during the reaction, thereby complicating purification. 
Nevertheless, we were able to isolate small amounts of the amide product for testing. 
The two compounds containing the linking amide and triazole functionalities were 
screened in 3 cell lines: DLD1, PANC1, NCI/ADR (Figure 4.5). The amide appears to be 
tolerated in all lines whereas the triazole is evidently tolerated in only the DLD1 line. We 
are currently trying to understand why this is the case (vide infra) and, at the time of this 
writing, confirming our results with a larger panel of tumor cell lines at the National 
Cancer Institute. However, the data tentatively suggest that Dictyostatin's C6 methyl can 
be derivatized without significant loss of activity. 
 
Figure 4.5: EC50 Values for C6 Analogues of DCT (Columbia Genome Center) 
 
V. Future Directions 
We plan to prepare additional compounds that extend the DCT C6 amide linker beyond a 
methyl group (Figure 4.6). In particular, we want to establish the tolerability for 
PEGylated linkers, given their well-known ability to improve pharmacokinetic properties, 
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Figure 4.6: Hypothetical C6-PEGylated DCT Analog   
 
We are also pursuing Dictyostatin's C12-Me and C22-Me ligation sites. Two late-stage 
fragments have been prepared, and we intend at some point to advance them to the final 
target compounds (Scheme 4.6). These analogues will then serve a number of purposes, 
including: (a) shedding light on the validity of the two competing models of Dictyostatin 
binding (Figure 4.1) and (b) establishing whether the amide and triazole trends observed 
in the C6 series are more general phenomena that carry over to the C12 and C22 series. 
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Lastly, we have extended our conjugation studies to include other microtubule-binding 
agents, in particular the spongistatins,25 epothilones,26 and Taxol. Taxol is an attractive 
testing ground because of its commercial availability; therefore, we can rapidly prepare 
analogs bearing different linker compositions. For example, given the DCT C6-triazole 
results previously discussed (Figure 4.5), we wanted to establish if Taxol exhibited the 
same behavior. Evidently, as depicted in Figure 4.7, the triazole group is also untolerated. 
Therefore, compounds derived from both Taxol and Dictyostatin indicate that the triazole 
may be interacting with key tubulin residues in the binding pocket and preventing ligand-
protein binding. We may conclude that the azide-alkyne click reaction is unlikely to be a 
conjugation reaction suitable for our purposes. 
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VI. Conclusion 
In this chapter, I have described the start of a new, long-term project within our group to 
advance small molecules into the clinic. We have identified an exceedingly rare family of 
highly cytotoxic natural products (i.e. microtubule-binding agents) that may be of import 
in the treatment of cancer. However, their likely systemic toxicities would preclude their 
usage in standard chemotherapies. Thus, we have begun to address the chemical question 
of conjugation such that in the future, these molecules may be adopted as the warheads of 
a targeted delivery vehicle. 
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VII. Supporting Information 
Experimental Procedures 
Compounds from the DCT C6 Series 
 
To a cooled (-78 °C) solution of methyl ketone (360 mg, 2.5:1 dr, 1.7 mmol, 1 equiv) in 
CH2Cl2 (17 mL, 0.1 M) was added 2,6-lutidine (778 µL, 6.9 mmol, 4.2 equiv) and TBS-
OTf (794 µL, 3.5 mmol, 2.1 equiv). The reaction mixture was allowed to warm to 0 °C as 
the dry ice bath expired. After 3h, the reaction mixture was re-cooled to -78 °C, and a 
solution of N-bromosuccinimide (352 mg, 2.0 mmol, 1.2 equiv) in THF (8.5 mL) was 
added over 30 min. After 3h, the reaction mixture was quenched with saturated aqueous 
NaHCO3 (20 mL). The aqueous layer was separated and extracted with CH2Cl2 (3x20 
mL). The combined organic layers were dried over MgSO4, filtered, and concentrated. 
Purification was accomplished by pH 7.0 buffered silica gel flash column 
chromatography (1% EtOAc/Hex) affording bromoketone as a mixture of C6 
diastereomers (530 mg, 2.5:1 dr, 78% combined yield). This material was used without 
further purification, and the separation of diastereomers was performed at a later stage. 
TLC Rf = 0.53 (10% EtOAc/Hex, one spot); IR (thin film) 2930, 2857, 1717, 1462, 
1253, 1074, 834, 776 cm-1; 1H NMR (500 MHz, CDCl3) δ 5.62 (ddd, J = 17.3, 10.3, 9.1 
Hz, 1H, C5H major), 5.59 (ddd, J = 17.2, 10.3, 8.6 Hz, 1H, C5H minor), 5.15 – 4.99 (m, 
2H, C4H2), 4.19 (ddd, J = 6.8, 5.7, 3.0 Hz, 1H, C7H major), 4.13 (ddd, J = 7.1, 5.5, 4.3 
Hz, 1H, C7H minor), 3.90 (s, 2H, C10H2 minor), 3.88 (s, 2H, C10H2 major), 3.51 (t, J = 
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tt, J = 9.3, 3.3 Hz, 1H, C6H major), 1.83 – 1.67 (m, 2H), 1.58 – 1.43 (m, 2H), 1.37 – 1.19 
(m, 2H), 0.87 (s, 9H, TBS), 0.08 (s, 3H, TBS), 0.01 (s, 3H, TBS); 13C NMR (125 MHz, 
CDCl3) δ (major diastereomer) 200.7, 138.1, 117.8, 71.6, 50.0, 45.1, 44.7, 35.8, 32.8, 
29.4, 26.0, 25.0, 18.2, -4.4, -4.5; HMRS: Exact mass calcd for C17H31BrClO2Si [M–H]-: 
409.0965; found 409.0971 (FAB+). 
 
 
Bromoketone (880 mg, 2.5:1 dr, 2.1 mmol, 1 equiv) and methyldiphenylphosphite (686 
µL, 3.2 mmol, 2 equiv) were heated together neat at 140 °C. After 7h, aliquot 1H-NMR 
indicated full conversion to the bis-phenyl phosphonate (this reaction time may vary 
depending on the scale of the reaction). The reaction mixture was cooled to 0 °C. 
Trifluoroethanol (9.3 mL, 60 equiv), THF (4.7 mL), and DBU (479 µL, 3.2 mmol, 1.5 
equiv) were added. The reaction mixture was heated to 45 °C. After 1h, the reaction 
mixture was cooled to room temperature and filtered over a silica gel plug, eluting with 
50% EtOAc/Hex (250 mL). The filtrate was concentrated and purified by silica gel flash 
column chromatography (2-20% EtOAc/Hex) affording bis-trifluoroethyl phosphonate as 
a mixture of C6 diastereomers (732 mg, 2.5:1 dr, 60% combined yield). This material 
was used without further purification, and the separation of diastereomers was performed 
at a later stage. TLC Rf = 0.4 (20% EtOAc/Hex); IR (thin film) 2932, 2859, 1718, 1294, 
1259, 1169, 1069, 962, 836 cm-1; 1H NMR (500 MHz, CDCl3) δ 5.65 – 5.51 (m, 1H, 
C5H), 5.15 – 4.96 (m, 2H, C4H2), 4.48 – 4.37 (m, 4H, TFE), 4.16 (app. td, J = 6.1, 2.9 Hz, 
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α-Cl), 3.34 – 3.17 (m, 2H, C10H2), 2.75 – 2.58 (m, 2H, C8H2), 2.14 – 2.01 (m, 1H, C6H), 
1.82 – 1.67 (m, 2H), 1.57 – 1.41 (m, 2H), 1.37 – 1.18 (m, 2H), 0.86 (s, 9H, TBS), 0.07 (s, 
3H, TBS), 0.01 (s, 3H, TBS); 13C NMR (125 MHz, CDCl3) δ (major diastereomer) 200.1 
(d, 2JC,P = 7.0 Hz), 138.0, 122.6 (qd, J = 277.6, 8.6 Hz, 2C), 117.8, 70.9, 62.6 (qd, J = 
38.1, 5.4 Hz), 62.5 (qd, J = 38.1, 5.3 Hz), 49.9, 49.1 (d, 3JC,P = 5.4 Hz), 45.0, 42.7 (d, 
1JC,P = 138.8 Hz), 32.8, 29.3, 25.9, 25.0, 18.1, -4.5, -4.6; HMRS: Exact mass calcd for 
C21H35ClF6O5PSi [M–H]-: 575.1584; found 575.1602 (FAB+). 
 
 
To a solution of chloride (354 mg, 0.61 mmol, 1 equiv) in DMF (5 mL, 0.12 M) was 
added NaN3 (48 mg, 0.74 mmol, 1.2 equiv). The reaction mixture was heated to 70 °C. 
After 7h, aliquot 1H-NMR indicated full conversion of starting material. The reaction 
mixture was allowed to cool to room temperature and directly purified by silica gel flash 
column chromatography (5-30% EtOAc/Hex) affording azide as a mixture of C6 
diastereomers (310 mg, 87% yield). This material was used without further purification, 
and the separation of diastereomers was performed at a later stage. TLC Rf = 0.55 (30% 
EtOAc/Hex; product co-spots with starting material); IR (thin film) 2932, 2859, 2096, 
1718, 1259, 1170, 1068, 836 cm-1; 1H NMR (500 MHz, CDCl3) δ (major diastereomer) 
5.60 (ddd, J = 17.2, 10.3, 9.0 Hz, 1H, C5H), 5.13 (dd, J = 10.3, 1.9 Hz, 1H, C4Ha), 5.00 
(dd, J = 17.2, 1.9 Hz, 1H, C4Hb), 4.50 – 4.37 (m, 4H, TFE), 4.16 (app. td, J = 6.1, 2.9 Hz, 
1H, C7H), 3.29 – 3.21 (m, 4H, C10H2, α-N3), 2.69 – 2.65 (m, 2H, C8H2), 2.06 (app. ddd, J 
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TBS), 0.08 (s, 3H, TBS), 0.02 (s, 3H, TBS); 13C NMR (125 MHz, CDCl3) δ (major 
diastereomer) 200.1 (d, 2JC,P = 6.9 Hz), 138.0, 122.6 (qd, J = 277.5, 8.2 Hz, 2C), 117.9, 
71.0, 62.6 (qd, J = 38.0, 5.4 Hz), 62.5 (qd, J = 37.9, 5.3 Hz), 51.5, 50.0, 49.2 (d, 3JC,P = 
5.1 Hz), 42.8 (d, 1JC,P = 138.8 Hz), 30.0, 29.0, 25.9, 24.9, 18.2, -4.5, -4.5; LRMS: Exact 
mass calcd for C21H37F6N3O5PSi [M+H]+: 584.2; found 584.2 (FAB+). 
 
 
To a solution of phosphonate (191 mg, 0.33 mmol, 1 equiv) and vinyl iodide (195 mg, 
0.65 mmol, 2 equiv) in MeCN (3.3 mL, 0.1 M) was added AgOAc (109 mg, 0.65 mmol, 
2 equiv) and Pd(OAc)2 (2.2 mg, 0.0098 mmol, 3 mol%). The reaction mixture was heated 
to 45 °C. Additional Pd(OAc)2 was added at t = 16h (2.2 mg, 3 mol%) and t = 24h (1.1 
mg, 1.5 mol%; 7.5 mol% total). After a total reaction time of 40h, the reaction mixture 
was cooled to room temperature and filtered over celite, eluting with 50% EtOAc/Hex 
(50 mL) The filtrate was washed with pH 7.0 buffer solution (20 mL). The aqueous layer 
was separated and extracted with 50% EtOAc/Hex (3x20 mL). The combined organic 
layers were dried over MgSO4, filtered, and concentrated. Purification was accomplished 
by pH 7.0 buffered silica gel flash column chromatography (10-20% EtOAc/Hex) 
affording pure fractions of cis-dienoate (74 mg, 30% yield) and mixed fractions of C6 
epimers (68 mg, 28% yield; 58% combined yield). TLC Rf = 0.50 (35% EtOAc/Hex); 
[α]22D -4.0 (c = 1.0, CH2Cl2); IR (thin film) 2953, 2858, 2096, 1713, 1254, 1172, 1069, 
837 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.35 (dd, J = 15.5, 11.1 Hz, 1H, C4H), 6.53 (t, J 
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C2H), 4.49 – 4.39 (m, 4H, TFE), 4.24 – 4.17 (m, 3H, TMSE, C7H), 3.34 – 3.20 (m, 2H, 
C10H2), 3.25 (t, J = 6.9 Hz, 2H, α-N3), 2.67 (d, J = 6.1 Hz, 2H, C8H2), 2.26 – 2.19 (m, 1H, 
C6H), 1.64 – 1.52 (m, 3H), 1.44 – 1.32 (m, 2H), 1.32 – 1.24 (m, 1H), 1.04 – 0.99 (m, 2H, 
TMSE), 0.87 (s, 9H, TBS), 0.09 (s, 3H, TBS), 0.05 (s, 9H, TMSE), 0.02 (s, 3H, TBS); 
13C NMR (125 MHz, CDCl3) δ 199.7 (d, 2JC,P = 6.9 Hz), 166.7, 144.3, 143.6, 129.6, 
122.6 (qd, J = 277.5, 8.1 Hz, 2C), 117.3, 70.7, 62.5 (qt, J = 38.0, 5.9 Hz, 2C), 62.3, 51.4, 
49.6 (d, 3JC,P = 4.9 Hz), 49.1, 42.7 (d, 1JC,P = 137.9 Hz), 30.3, 29.0, 26.0, 24.9, 18.2, 17.5, 
-1.4, -4.4, -4.6; LRMS: Exact mass calcd for C29H50F6N3NaO7PSi2 [M+Na]+: 776.27; 
found 776.18 (FAB+). 
 
 
To a cooled (-78 °C) solution of phosphonate (60 mg, 0.08 mmol, 1.5 equiv) in THF (1 
mL, 0.05 M) was added NaHMDS (1M THF, 69 µL, 0.069 mmol, 1.3 equiv). After 20 
min, aldehyde (37 mg, 0.23 mmol, 1 equiv) was added, and the reaction mixture was 
allowed to warm to room temperature. After 48h, the reaction mixture was quenched at 0 
°C with a solution of PPTS (5 mg) in MeOH (2 mL) to deprotect the C21 TMS ether. 
After 2h, the reaction mixture was diluted with pH 7.0 buffer solution (10 mL). The 
aqueous layer was separated and extracted with EtOAc (5x30 mL). The combined 
organic layers were dried over MgSO4, filtered, and concentrated. Purification was 
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3:1 Z:E mixture of enone (44 mg, 75% yield of Z-isomer) as a colorless oil. TLC Rf = 
0.50 (10% EtOAc/Hex); [α]22D -14.7 (c = 0.33, CH2Cl2); IR (thin film) 2930, 2862, 
2095, 1713, 1637, 1604, 1461, 1251, 1172, 1059, 835, 774, 675 cm-1; 1H NMR (500 
MHz, CDCl3) δ 7.37 (dd, J = 15.5, 11.3 Hz, 1H, C4H), 6.66 (dt, J = 16.9, 10.6 Hz, 1H, 
C25H), 6.57 (t, J = 11.3 Hz, 1H, C3H), 6.32 (dd, J = 11.6, 9.7 Hz, 1H, C11H), 6.09 (t, J = 
11.0 Hz, 1H, C24H), 6.03 (d, J = 11.7 Hz, 1H, C24H), 5.94 (dd, J = 15.5, 9.4 Hz, 1H, 
C10H), 5.61 (d, J = 11.3 Hz, 1H, C2H), 5.49 (t, J = 10.3 Hz, 1H, C23H), 5.21 (dd, J = 16.9, 
2.0 Hz, 1H, C26Ha), 5.12 (d, J = 10.3 Hz, 1H, C26Hb), 4.31 (td, J = 6.0, 2.6 Hz, 1H, C7H), 
4.26 – 4.21 (m, 2H, TMSE), 4.01 – 3.93 (m, 1H, C19H), 3.77 – 3.67 (m, 1H, C12H), 3.60 
– 3.56 (m, 1H, C12H), 3.50 (app. t, J = 3.4 Hz, 1H, C21H), 3.26 (t, J = 7.0 Hz, 2H, α-N3), 
2.88 – 2.80 (m, 1H, C22H), 2.78 (d, J = 1.7 Hz, 1H, OH), 2.61 – 2.50 (m, 2H, C8H2), 2.27 
– 2.19 (m, 1H, C14H); 13C NMR (125 MHz, CDCl3) δ 199.3, 166.7, 152.5, 144.8, 144.6, 
135.9, 132.6, 129.6, 129.3, 125.4, 117.6, 116.7, 79.9, 79.3, 78.5, 71.0, 62.2, 51.5, 50.1, 
49.5, 41.2, 37.4, 36.5, 36.2, 36.1, 32.7, 31.9, 30.9, 30.9, 29.1, 26.3, 26.1, 25.0, 20.7, 19.3, 
18.6, 18.5, 18.4, 18.2, 18.0, 17.6, 15.9, 13.6, 5.9, -1.3, -3.5, -3.8, -4.1, -4.6. 
 
 
C1 Deprotection: To a cooled (0 °C) solution of TMSE ester (44 mg, 0.039 mmol, 1 
equiv) in DMF (3.9 mL, 0.01M) was added a solution of TAS-F (11 mg, 0.041, 1.05 
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temperature. After 20h, the reaction mixture was diluted with Et2O (10 mL) and 
quenched at 0 °C with 1M NaHSO4 (5 mL). The reaction mixture was further diluted 
with saturated aqueous NaCl (5 mL) and extracted with Et2O (5x10 mL). The combined 
organic layers were dried over MgSO4, filtered, and concentrated. The crude acid was 
used immediately without purification. Macrolactonization: To a solution of acid 
(assume 1 equiv) in Toluene (39 mL, 0.001M) was added 2-methyl-6-nitrobenzoic 
anhydride (41 mg, 0.12 mmol, 3 equiv), DMAP (5 mg, 0.039 mmol, 1 equiv), and NEt3 
(55 µL, 0.39 mmol, 10 equiv). After 24h, the reaction mixture was quenched with 
saturated aqueous NaHCO3 (20 mL) The aqueous layer was separated and extracted with 
EtOAc (3x50 mL). The combined organic layers were dried over MgSO4, filtered, and 
concentrated. Purification was accomplished by pH 7.0 buffered silica gel flash column 
chromatography (1-5% EtOAc/Hex) affording macrocycle (21 mg, 54% yield over 2 
steps). TLC Rf = 0.52 (10% EtOAc/Hex); [α]19D -9.7 (c = 1.0, CH2Cl2); IR (thin film) 
2931, 2864, 2096, 1707, 1462, 1380, 1255, 1051, 836, 775 cm-1; 1H NMR (500 MHz, 
CDCl3) δ 7.13 (dd, J = 15.6, 11.1 Hz, 1H, C4H), 6.62 – 6.52 (m, 2H, C25H, C3H), 6.38 
(dd, J = 11.7, 10.2 Hz, 1H, C11H), 6.09 (d, J = 11.7 Hz, 1H, C10H), 6.04 (t, J = 11.2 Hz, 
1H, C24H), 5.91 (dd, J = 15.5, 9.0 Hz, 1H, C5H), 5.61 (d, J = 11.6 Hz, 1H, C2H), 5.47 (t, J 
= 10.8 Hz, 1H, C23H), 5.36 (dd, J = 9.1, 2.9 Hz, 1H, C21H), 5.21 (d, J = 16.8 Hz, 1H, 
C26Ha), 5.13 (d, J = 10.6 Hz, 1H, C26Hb), 4.17 – 4.11 (m, 1H, C7H), 3.89 – 3.80 (m, 1H, 
C19H), 3.80 – 3.69 (m, 1H, C12H), 3.32 (dd, J = 5.7, 2.0 Hz, 1H, C13H), 3.26 (t, J = 7.0 
Hz, 2H, α-N3), 3.19 – 3.11 (m, 1H, C22H), 2.61 (dd, J = 13.8, 6.8 Hz, 1H, C8Ha), 2.45 
(dd, J = 13.8, 4.9 Hz, 1H, C8Hb), 2.13 (m, 1H, C6H); 13C NMR (125 MHz, CDCl3) δ 
198.9, 166.7, 151.6, 142.5, 142.4, 133.1, 131.9, 130.5, 130.1, 125.2, 118.5, 118.4, 81.2, 
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79.0, 72.3, 52.4, 51.4, 50.5, 42.7, 39.4, 37.6, 36.1, 33.8, 32.2, 31.6, 29.9, 29.9, 29.0, 26.4, 
26.0, 25.0, 20.7, 19.1, 18.7, 18.5, 18.5, 18.2, 15.6, 13.4, 9.0, -3.2, -3.4, -3.9, -4.5; LRMS: 
Exact mass calcd for C53H103N3NaO6Si3 [M+Na]+: 1020.7; found 1020.8 (FAB+). 
 
 
To a cooled (-78° C) solution of enone (18 mg, 18 µmol, 1 equiv) in Toluene (360 µL, 
0.05M) was added (R)-2-Methyl-CBS oxazaborolidine (1M Tol, 90 µL, 90 µmol, 5 
equiv) and catecholborane (50% w/w Toluene, 50 µL, 0.18 mmol, 10 equiv). After 24h, 
the reaction mixture was quenched with MeOH (2 mL) and then saturated aqueous 
NaHCO3 (2 mL). The aqueous layer was separated and extracted with Et2O (5x10 mL). 
The combined organic layers were dried over MgSO4, filtered, and concentrated. 
Purification was accomplished by silica gel flash column chromatography (5-10% 
EtOAc/Hex) affording allylic alcohol (14 mg, 79% yield). TLC Rf = 0.32 (10% 
EtOAc/Hex); [α]22D -114 (c = 0.1, CH2Cl2); IR (thin film) 3492, 2930, 2863, 2096, 1711, 
1462, 1254, 1052, 836, 775, 678 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.04 (dd, J = 15.4, 
11.4 Hz, 1H, C4H), 6.57 (dt, J = 16.9, 10.5 Hz, 1H, C25H), 6.52 (t, J = 11.4 Hz, 1H, C3H), 
6.06 (t, J = 11.1 Hz, 1H, C24H), 5.98 (dd, J = 15.7, 7.6 Hz, 1H, C5H), 5.69 (t, J = 9.9 Hz, 
1H, C11H), 5.60 (d, J = 11.4 Hz, 1H, C2H), 5.43 – 5.35 (m, 2H, C23H, C10H), 5.28 – 5.17 
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(dt, J = 9.9, 2.9 Hz, 1H, C7H), 3.77 (bs, 1H, C19H), 3.23 (m, 3H, C13H, α-N3), 3.13 – 3.03 
(m, 1H, C22H), 2.73 – 2.64 (m, 1H, C12H), 2.38 – 2.24 (m, 1H, C6H), 1.86 (bs, 1H, C20H). 
 
 
To a cooled (0 °C) solution of protected-DCT (14 mg, 0.014 mmol, 1 equiv) in THF (2 
mL) in a Nalgene tube was added pyridinium hydrofluoride (100 µL). The reaction 
mixture was allowed to warm to room temperature. At t = 24h, 48h, and 60h, additional 
pyridinium hydrofluoride (100 µL) was added. After a total reaction time of 90h, the 
reaction mixture was slowly quenched at 0 °C with saturated aqueous NaHCO3 (10 mL) 
and then diluted with CH2Cl2 (20 mL). The aqueous layer was separated and extracted 
with CH2Cl2 (5x20 mL). The combined organic layers were dried over MgSO4, filtered, 
and concentrated. Purification was accomplished by silica gel flash column 
chromatography (50-100% EtOAc/Hex) affording product (6.5 mg, 76% yield). TLC Rf 
= 0.48 (80% EtOAc/Hex); [α]18D 48.5 (c = 0.1, CH2Cl2); IR (thin film) 3403, 2925, 
2096, 1694, 1456, 1277, 1042, 961 cm-1; 1H NMR (500 MHz, CDCl3) δ 7.34 (dd, J = 
15.8, 11.3 Hz, 1H, C4H), 6.64 – 6.55 (m, 1H, C25H), 6.49 (t, J = 11.3 Hz, 1H, C3H), 6.02 
(dd, J = 15.9, 7.4 Hz, 1H, C5H), 5.99 (t, J = 11.0 Hz, 1H, C24H), 5.57 (t, J = 10.2 Hz, 1H, 
C10H), 5.49 (d, J = 11.3 Hz, 1H, C2H), 5.34 (t, J = 10.5 Hz, 1H, C11H), 5.26 (t, J = 10.5 
Hz, 1H, C23H), 5.18 (dd, J = 16.9, 1.9 Hz, 1H, C26Ha), 5.10 (d, J = 10.1 Hz, 1H, C26Hb), 
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1H, C7H), 3.51 – 3.46 (m, 1H, C19H), 3.30 – 3.24 (m, 3H, C13H, α-N3), 3.04 – 2.94 (m, 
1H, C22H), 2.81 – 2.70 (m, 1H, C12H), 2.27 – 2.20 (m, 1H, C6H), 1.91 – 1.83 (m, 1H, 
C20H), 1.06 (d, J = 6.8 Hz, 3H, C20CH3), 1.00 (d, J = 6.7 Hz, 3H, C22CH3), 0.94 (app. t, J 
= 6.5 Hz, 6H, C12CH3, C14CH3), 0.90 (d, J = 6.4 Hz, 3H, C16CH3); 13C NMR (125 MHz, 
CDCl3) δ 166.7, 145.7, 145.2, 134.9, 134.0, 133.0, 132.2, 130.3, 128.5, 118.1, 116.3, 
76.3, 76.2, 73.3, 70.1, 66.5, 51.5, 47.5, 42.4, 40.0, 38.9, 35.3, 35.3, 32.1, 31.6, 31.4, 29.9, 
29.5, 29.3, 24.5, 21.3, 17.8, 17.6, 14.2, 10.4. 
Compounds from the DCT C12 Series 
 
Silylformylation: To the glass liner of a Parr bomb was added 6-chloro-1-hexyne (500 
mg, 4.3 mmol, 1 equiv), diphenyl-isopropoxy-silane (1g, 4.3 mmol, 1 equiv), and 
benzene (4.3 mL, 1M). The glass liner was cooled to -78 °C, and Rh(acac)(CO)2 (11 mg, 
0.043 mmol, 1 mol%) was added on top of the frozen benzene solution. While still 
frozen, the glass liner was placed into the Parr bomb and charged to 300 psi with CO 
(vented and re-charged 3X). The pressure was maintained between 200-300 psi during 
the reaction. After 5h, aliquot 1H-NMR indicated full conversion of alkyne. The reaction 
mixture was concentrated, and the crude aldehyde was used without purification. 
Crotylation: To a solution of aldehyde (assume 1 equiv) in CH2Cl2 (43 mL, 0.1 M) was 
added (S,S)-cis-crotylsilane (2.7 g, 4.7 mmol, 1.1 equiv) and Sc(OTf)3 (106 mg, 0.21 
mmol, 5 mol%). After vigorously stirring for 3h, the reaction mixture was quenched at 0 
°C with TBAF (6 mL, 1M THF). After 1h, the reaction mixture was concentrated and 
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(1.5 g, >20:1 dr, ee not determined, 91% yield). TLC Rf = 0.6 (10% EtOAc/Hex); [α]19D 
-20.7 (c = 2.0, CH2Cl2); IR (thin film) 2934, 1580, 1428, 1113, 996, 822, 739, 699 cm-1; 
1H NMR (500 MHz, CDCl3) δ 7.66 – 7.63 (m, 2H), 7.53 – 7.50 (m, 2H), 7.47 – 7.32 (m, 
6H), 6.09 (ddd, J = 16.5, 9.8, 6.7 Hz, 1H, C15H), 6.05 (d, J = 1.7 Hz, 1H, C11H), 5.14 – 
5.05 (m, 2H, C16H2), 4.87 (t, J = 2.1 Hz, 1H, C13H), 3.59 (t, J = 6.4 Hz, 2H, α-Cl), 2.59 – 
2.52 (m, 1H, C14H), 2.31 – 2.16 (m, 2H), 1.91 – 1.84 (m, 2H), 1.84 – 1.76 (m, 2H), 0.76 
(d, J = 6.9 Hz, 3H, C14CH3); 13C NMR (125 MHz, CDCl3) δ 167.0, 142.6, 135.8, 135.1, 
135.0, 134.7, 130.2, 127.9, 127.9, 119.2, 114.0, 88.3, 45.0, 40.9, 32.4, 31.5, 25.0, 12.3; 
HRMS: Exact mass calcd for C23H26OClSi [M–H]-: 381.1441; found 381.1448 (FAB+). 
 
 
Tamao Oxidation: To a cooled (0 °C) solution of vinylsilane (480 mg, 1.3 mmol, 1 
equiv) in 1:1 THF / iPrOH (13 mL, 0.1 M) was added KHCO3 (125 mg, 1.3 mmol, 1 
equiv) and H2O2 (1.6 mL, 16 mmol, 13 equiv, 30% wt in H2O). After 1h, the reaction 
mixture was diluted with Et2O (10 mL) and quenched with distilled H2O (5 mL). The 
aqueous layer was separated and extracted with Et2O (3x10 mL). The combined organic 
layers were dried over MgSO4, filtered, and concentrated. The crude aldehyde was used 
immediately without purification. Aldehyde Protection: To a solution of aldehyde 
(assume 1 equiv) in Toluene (6.3 mL, 0.2M) was added ethylene glycol (701 µL, 13 
mmol, 10 equiv) and PPTS (200 mg, 0.80 mmol, 0.64 equiv). The reaction mixture was 
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and directly purified by silica gel flash column chromatography affording product as an 
inseparable mixture of C12 diastereomers (180 mg, 10:1 dr, 55% combined yield). This 
material was used without further purification, and the separation of diastereomers was 
performed at a later stage. TLC Rf = 0.38 (25% EtOAc/Hex); IR (thin film) 3523 (bs), 
2877, 1639, 1458, 1406, 1100, 999, 915 cm-1; 1H NMR (500 MHz, CDCl3) δ 5.74 (ddd, J 
= 17.3, 10.4, 8.1 Hz, 1H, C15H major), 5.61 (ddd, J = 17.1, 10.3, 8.9 Hz, 1H, C15H 
minor), 5.12 – 4.93 (m, 3H, C16H2, C11H), 4.06 – 3.94 (m, 2H), 3.93 – 3.80 (m, 2H), 3.72 
(dd, J = 9.6, 1.4 Hz, 1H, C13H minor), 3.56 – 3.51 (m, 2H, α-Cl), 3.49 (dd, J = 7.5, 4.8 
Hz, 1H, C13H major), 2.82 (bs, 1H, OH), 2.47 – 2.29 (m, 1H, C14H), 2.00 – 1.94 (m, 1H, 
C12H major), 1.93 – 1.89 (m, 1H, C12H minor), 1.83 – 1.72 (m, 2H), 1.64 – 1.40 (m, 4H), 
1.14 – 1.08 (m, 3H, C14CH3); 13C NMR (125 MHz, CDCl3) δ (major diastereomer) 
141.7, 114.9, 104.9, 75.0, 65.2, 64.8, 45.1, 42.5, 42.2, 33.1, 24.9, 24.8, 16.2; HRMS: 
Exact mass calcd for C13H22O3Cl [M–H]-: 261.1257; found 261.1269 (FAB+). 
 
 
Ozonolysis: To a cooled (-78 °C) solution of olefin (58 mg, 4.7:1 dr, 0.22 mmol, 1 equiv) 
in CH2Cl2 (2.2 mL, 0.1 M) was bubbled in ozone. Immediately after the solution began 
turning blue, the reaction mixture was purged with oxygen until colorless. PPh3 (64 mg, 
0.24 mmol, 1.1 equiv) was added, and the reaction mixture was allowed to warm to room 
temperature. Wittig: After 12h, the reaction mixture was diluted with toluene (2.2 mL). 
Phosphonium salt (92 mg, 0.26 mmol, 1.2 equiv) was added, and the reaction mixture 
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added. After a total reaction time of 10h, the reaction mixture was directly purified by 
silica gel flash column chromatography (5% EtOAc/Hex; then 20-40% EtOAc/Hex) 
affording methyl ester as a mixture of C12 diastereomers (58 mg, 4.7:1 dr, 78% 
combined yield). This material was used without further purification, and the separation 
of diastereomers was performed at a later stage. TLC Rf = 0.37 (30% EtOAc/Hex); IR 
(thin film) 3515 (bs), 2951, 2873, 1710, 1436, 1273, 1225, 1123, 1101, 988, 752 cm-1; 1H 
NMR (500 MHz, CDCl3) δ 6.59 (dd, J = 10.2, 1.5 Hz, 1H, C15H major), 6.51 (dd, J = 
10.6, 1.5 Hz, 1H, C15H minor), 4.92 (d, J = 2.4 Hz, 1H, C11H minor), 4.89 (d, J = 3.3 Hz, 
1H, C11H major), 4.04 – 3.92 (m, 2H), 3.92 – 3.80 (m, 2H), 3.72 (s, 3H), 3.58 – 3.48 (m, 
3H, C13H, α-Cl), 2.93 (d, J = 7.4 Hz, 1H, OH major), 2.80 – 2.66 (m, 1H, C14H), 1.85 (d, 
J = 1.5 Hz, 3H, C16CH3), 1.83 – 1.68 (m, 3H, C12H), 1.59 – 1.42 (m, 4H), 1.10 (d, J = 6.7 
Hz, 3H, C12CH3 minor), 1.09 (d, J = 6.6 Hz, 3H, C12CH3 major); 13C NMR (125 MHz, 
CDCl3) δ (major diastereomer) 168.5, 144.2, 126.9, 104.9, 74.9, 65.0, 64.6, 51.8, 44.8, 
43.2, 37.8, 32.9, 25.2, 24.5, 16.0, 12.6; HMRS: Exact mass calcd for C16H26ClO5 [M–H]-
: 333.1469; found 333.1481 (FAB+). 
 
 
Hydrogenation: To the glass liner of a Parr bomb was added alcohol (180 mg, 10:1 dr, 
0.54 mmol, 1 equiv) and CH2Cl2 (1.3 mL, 0.4M). The Parr bomb was charged to 300 psi 
with H2 and stirred overnight to saturate the solution with H2. Then, Crabtree’s catalyst (9 
mg, 0.005 mmol, 2 mol%) was added, and the bomb was charged to 300 psi with H2. 
















Oi) Crabtree's cat.ii) TBS-OTf
~75%
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total reaction time of 20h, aliquot 1H-NMR indicated >90% conversion of the major C12 
diastereomer; the minor C12 diastereomer did not appreciably react. Alcohol Protection: 
The glass liner was removed from the bomb and cooled to -78 °C. 2,6-lutidine (249 µL, 
2.2 mmol, 4 equiv) and TBS-OTf (247 µL, 1.1 mmol, 2 equiv) were added. After 6h, the 
reaction mixture was quenched with saturated aqueous NH4Cl (10 mL). The aqueous 
layer was separated and extracted with CH2Cl2 (3x20 mL). The combined organic layers 
were dried over MgSO4, filtered, and concentrated. Purification was accomplished by 
silica gel flash column chromatography (2-5% EtOAc/Hex) affording a mixture of 
product and C12 unsaturated isomers (181 mg, 75% combined yield). This material was 
used without further purification, and the separation was performed at a later stage. TLC 
Rf = 0.33 (10% EtOAc/Hex); IR (thin film) 2953, 2931, 1736, 1461, 1253, 1059, 835, 
773 cm-1; 1H NMR (500 MHz, CDCl3) δ (major diastereomer) 4.84 (d, J = 4.0 Hz, 1H, 
C11H), 3.98 – 3.89 (m, 2H), 3.84 – 3.76 (m, 2H), 3.69 (dd, J = 5.9, 2.4 Hz, 1H, C13H), 
3.65 (s, 3H), 3.52 (t, J = 6.7 Hz, 2H, α-Cl), 2.60 – 2.45 (m, 1H, C16H), 1.85 – 1.78 (m, 
1H, C12H), 1.78 – 1.64 (m, 4H), 1.61 – 1.39 (m, 5H, C15Ha), 1.24 (m, 1H, C15Hb), 1.15 (d, 
J = 6.9 Hz, 3H, C16CH3), 0.89 (s, 9H, TBS), 0.88 (d, J = 6.9 Hz, 3H, C14CH3), 0.06 (s, 
3H, TBS), 0.05 (s, 3H, TBS); 13C NMR (125 MHz, CDCl3) δ (major diastereomer) 
177.4, 105.2, 75.7, 64.9, 64.5, 51.6, 46.9, 45.1, 40.3, 37.5, 34.0, 33.4, 26.6, 26.3, 25.1, 
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To a cooled (-78 °C) solution of methyl ester (181 mg, 0.40 mmol, 1 equiv) in Toluene (4 
mL, 0.1M) was added DIBAL (1M Hex, 1.1 mL, 1.1 mmol, 2.7 equiv) dropwise. After 
6h, the reaction mixture was quenched with MeOH (4 mL) and then a saturated aqueous 
solution of Rochelle’s salt (10 mL). After vigorously stirring for 1h, the aqueous layer 
was separated and extracted with 50% EtOAc/Hex (4x50 mL). The combined organic 
layers were dried over MgSO4, filtered, and concentrated. Purification was accomplished 
by silica gel flash column chromatography (10-20% EtOAc/Hex) affording pure alcohol 
(120 mg, 71% yield). TLC Rf = 0.47 (39% EtOAc/Hex); [α]21D -10.2 (c = 0.8, CH2Cl2); 
IR (thin film) 3393 (bs), 2928, 2857, 1462, 1251, 1059, 834, 772 cm-1; 1H NMR (500 
MHz, CDCl3) δ 4.85 (d, J = 4.4 Hz, 1H, C11H), 3.97 – 3.90 (m, 2H), 3.84 – 3.77 (m, 2H), 
3.65 (dd, J = 5.0, 3.4 Hz, 1H, C13H), 3.53 (t, J = 6.7 Hz, 2H, α-Cl), 3.50 (dd, J = 10.8, 4.4 
Hz, 1H, C17Ha), 3.45 (dd, J = 10.8, 6.0 Hz, 1H, C17Hb), 1.89 – 1.66 (m, 5H, C12H, C14H, 
β-Cl, C16H), 1.57 – 1.37 (m, 5H, C15Ha), 0.98 – 0.93 (m, 1H, C15Hb), 0.94 (d, J = 6.7 Hz, 
2H, C16CH3), 0.90 (s, 9H, TBS), 0.89 (d, J = 6.8 Hz, 3H, C14CH3), 0.06 (s, 3H, TBS), 
0.05 (s, 3H, TBS); 13C NMR (125 MHz, CDCl3) δ 105.3, 75.8, 67.6, 64.8, 64.5, 46.8, 
45.1, 39.0, 33.3, 33.3, 33.1, 26.6, 26.3, 25.5, 18.6, 18.0, 15.8, -3.8, -3.9; HMRS: Exact 
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To a solution of chloride (120 mg, 0.28 mmol, 1 equiv) in DMF (1.9 mL, 0.15 M) was 
added NaN3 (20 mg, 0.31 mmol, 1.1 equiv). The reaction mixture was heated to 70 °C. 
After 6h, aliquot 1H-NMR indicated full conversion of starting material. The reaction 
mixture was allowed to cool to room temperature and directly purified by silica gel flash 
column chromatography (5-20% EtOAc/Hex) affording azide (120 mg, 98% yield). TLC 
Rf = 0.47 (39% EtOAc/Hex; product co-spots with starting material); [α]18D -5.9 (c = 2.0, 
CH2Cl2); IR (thin film) 3359 (bs), 2929, 2858, 2094, 1462, 1252, 1063, 835, 773 cm-1; 
1H NMR (500 MHz, CDCl3) δ 4.85 (d, J = 4.4 Hz, 1H, C11H), 3.98 – 3.89 (m, 2H), 3.84 
– 3.77 (m, 2H), 3.66 (dd, J = 5.1, 3.3 Hz, 1H, C13H), 3.50 (dd, J = 10.8, 4.5 Hz, 1H, 
C17Ha), 3.46 (dd, J = 10.8, 6.0 Hz, 1H, C17Hb), 3.26 (t, J = 6.9 Hz, 2H, α-N3), 1.88 – 1.77 
(m, 2H, C12H, C14H), 1.74 – 1.66 (m, 1H, C16H), 1.63 – 1.57 (m, 2H, β-N3), 1.53 – 1.38 
(m, 5H, C15Ha), 0.98 – 0.93 (m, 1H, C15Hb), 0.94 (d, J = 6.7 Hz, 3H, C16CH3), 0.90 (s, 
9H, TBS), 0.89 (d, J = 6.9 Hz, 3H, C14CH3), 0.06 (s, 3H, TBS), 0.05 (s, 3H, TBS); 13C 
NMR (125 MHz, CDCl3) δ 105.3, 75.8, 67.6, 64.8, 64.5, 51.5, 46.9, 39.0, 33.3, 33.1, 
29.5, 26.5, 26.3, 25.8, 18.6, 18.0, 15.9, -3.8, -3.9; HRMS: Exact mass calcd for 
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To a cooled (0 °C) solution of PPh3 (40 mg, 0.15 mmol, 1.1 equiv) and imidazole (48 mg, 
0.70 mmol, 5 equiv) in CH2Cl2 (2.8 mL, 0.1 M) was added iodine (70 mg, 0.28 mmol, 1.2 
equiv). After 10 min, alcohol (60 mg, 0.14 mmol, 1 equiv) was added, and the reaction 
mixture was allowed to warm to room temperature. After 12h, the reaction mixture 
directly purified by pH 7.0 buffered silica gel flash column chromatography (1-5% 
EtOAc/Hex) affording iodide (60 mg, 80% yield). TLC Rf = 0.56 (10% EtOAc/Hex); 
[α]17D -14.8 (c = 2.0, CH2Cl2); IR (thin film) 2928, 2861, 2093, 1461, 1251, 1067, 1032, 
835, 773 cm-1; 1H NMR (500 MHz, CDCl3) δ 4.85 (d, J = 4.2 Hz, 1H, C11H), 3.99 – 3.90 
(m, 2H), 3.84 – 3.78 (m, 2H), 3.68 (dd, J = 5.8, 2.6 Hz, 1H, C13H), 3.29 – 3.23 (m, 3H, 
C17Ha, α-N3, 3.15 (dd, J = 9.7, 5.9 Hz, 1H, C17Hb), 1.85 – 1.80 (m, 1H, C12H), 1.79 – 1.70 
(m, 1H, C14H), 1.63 – 1.56 (m, 2H), 1.53 – 1.37 (m, 5H), 1.31 (ddd, J = 13.3, 7.8, 5.3 Hz, 
1H, C15Ha), 1.11 (ddd, J = 13.5, 8.8, 6.0 Hz, 1H, C15Hb), 0.97 (d, J = 6.5 Hz, 3H, 
C16CH3), 0.90 (s, 9H, TBS), 0.87 (d, J = 6.7 Hz, 3H, C14CH3), 0.07 (s, 3H, TBS), 0.06 (s, 
3H, TBS); 13C NMR (125 MHz, CDCl3) δ 105.1, 75.6, 64.8, 64.4, 51.3, 46.9, 42.4, 33.0, 
31.5, 29.4, 26.4, 26.1, 25.4, 21.6, 18.4, 18.1, 14.5, -4.1 (2C); HRMS: Exact mass calcd 
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Compounds from the DCT C22 Series 
 
Cross-Metathesis: To a solution of allylboronic acid pinacol ester (900 µL, 4.8 mmol, 
1.2 equiv) and 6-chloro-1-hexene (1.9 mL, 14 mmol, 3.6 equiv) in CH2Cl2 (24 mL, 0.2 
M) was added 2nd generation Hoveyda-Grubbs catalyst (150 mg, 0.24 mmol, 5 mol%). 
The reaction mixture was refluxed for 7h at which point aliquot 1H-NMR indicated 
complete conversion of starting material. The reaction mixture was concentrated, and the 
residue was filtered over a silica gel plug, eluting with 2% EtOAc/Hex (200 mL), to 
remove ruthenium residue. The filtrate was concentrated, and the crude boronate was 
used without further purification. Crotylation: To a solution of boronate (assume 1.2 
equiv) in Toluene (8 mL, 0.5 M) was added aldehyde27 (455 mg, 4 mmol, 1 equiv). After 
96h, the reaction mixture was quenched with MeOH (20 mL) to hydrolyze the boronate. 
After 1h, the reaction mixture was concentrated and purified by silica gel flash column 
chromatography (10-20% EtOAc/Hex) affording product as a mixture of C22 
diastereomers (889 mg, 81% combined yield, 3.7:1 dr). This material was used without 
further purification, and the separation of diastereomers was performed at a later stage. 
TLC Rf = 0.29 (20% EtOAc/Hex); IR (thin film) 3515 (bs), 2939, 1639, 1448, 1376, 
1312, 1167, 1042 cm-1; 1H NMR (500 MHz, CDCl3) δ 5.65 (dt, J = 17.1, 9.8 Hz, 1H, 
C23H), 5.19 – 5.06 (m, 2H, C24H2), 4.04 – 3.93 (m, 4H), 3.80 (dd, J = 8.6, 1.5 Hz, 1H, 
C21H major), 3.55 – 3.47 (m, 2H, α-Cl), 2.69 (bs, 1H, OH), 2.16 – 2.04 (m, 1H, C22H), 
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1.42 – 1.14 (m, 3H), 0.98 (d, J = 7.1 Hz, 3H, C20CH3); 13C NMR (125 MHz, CDCl3) δ 
(major diastereomer) 140.1, 117.2, 112.8, 72.1, 65.0, 64.5, 48.5, 45.1, 42.4, 32.8, 30.0, 




Ozonolysis: To a cooled (-78 °C) solution of olefin (200 mg, 3.7:1 dr, 0.72 mmol, 1 
equiv) in CH2Cl2 (7.2 mL, 0.1 M) was bubbled in ozone. After the solution turned blue, 
the reaction mixture was purged with oxygen until colorless. PPh3 (208 mg, 0.79 mmol, 
1.1 equiv) was added, and the reaction mixture was allowed to warm to room 
temperature. After 16h, the reaction mixture was concentrated and azeotroped with 
benzene (5x10 mL). The crude aldehyde was used immediately without purification. 
Matteson/Peterson Olefination: To a cooled (0 °C) solution of aldehyde (assume 1 
equiv) in Et2O (723 µL, 1M) was added powdered 4Å molecular sieves (150 mg) and 
Matteson's boronate reagent28 (694 mg, 2.9 mmol, 4 equiv). After 96h, the reaction 
mixture was cooled to 0 °C. EtOH (2.4 mL) was added, followed by 6M KOH (2.4 mL, 
14 mmol, 20 equiv). The reaction mixture was allowed to warm to room temperature. 
After 36h, the reaction mixture was neutralized at 0 °C with 3M HCl. The aqueous layer 
was separated and extracted with 50% EtOAc/Hex (3x20 mL). The combined organic 
layers were dried over MgSO4, filtered, and concentrated. Purification was accomplished 
by silica gel flash column chromatography (10-25% EtOAc/Hex) affording cis-diene as a 






















then KOH / EtOH
72% (2 steps)
	  
	   135 
used without further purification, and the separation of diastereomers was performed at a 
later stage. TLC Rf = 0.40 (30% EtOAc/Hex, one spot); IR (thin film) 3516 (bs), 2937, 
1447, 1375, 1218, 1166, 1039, 902, 870 cm-1; 1H NMR (500 MHz, CDCl3) δ (major 
diastereomer) 6.68 – 6.58 (m, 1H, C25H), 6.23 (t, J = 11.1 Hz, 1H, C24H), 5.31 (t, J = 10.6 
Hz, 1H, C23H), 5.23 (dd, J = 16.8, 2.0 Hz, 1H, C26Ha), 5.12 (d, J = 10.2 Hz, 1H, C26Hb), 
4.04 – 3.93 (m, 4H), 3.81 (dd, J = 8.3, 1.5 Hz, 1H, C21H), 3.50 (t, J = 6.7 Hz, 2H, α-Cl), 
2.71 – 2.60 (m, 2H, C22H, OH), 1.95 (qd, J = 7.1, 1.4 Hz, 1H, C20H), 1.83 – 1.64 (m, 2H), 
1.52 – 1.39 (m, 2H), 1.33 (s, 3H, C17H3), 1.30 – 1.14 (m, 2H), 1.02 (d, J = 7.1 Hz, 3H, 
C20CH3); 13C NMR (125 MHz, CDCl3) δ (major diastereomer) 134.1, 132.6, 131.9, 
118.2, 112.8, 72.7, 65.0, 64.5, 45.0, 42.7, 41.9, 32.9, 30.9, 24.5, 22.3, 7.8; HRMS: Exact 
mass calcd for C16H27ClO3Na [M+Na]+: 325.1546; found 325.1559 (FAB+). 
 
 
Chloride-to-Azide: To a solution of chloride (440 mg, 3.7:1 dr, 1.45 mmol, 1 equiv) in 
DMF (9.7 mL, 0.15M) was added NaN3 (104 mg, 1.60 mmol, 1.1 equiv). The reaction 
mixture was heated to 70 °C. After 6h, aliquot 1H-NMR indicated full conversion of 
starting material. The reaction mixture was allowed to cool to room temperature and 
filtered over celite, eluting with 50% EtOAc/Hex (100 mL). The filtrate was 
concentrated, and the crude azide was used immediately without further purification. 
Ketal Deprotection: To a solution of azide (assume 1 equiv) in 1:1 acetone / H2O (9.7 
mL, 0.15M) was added PPTS (183 mg, 0.73 mmol, 0.5 equiv). The reaction mixture was 
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aqueous layer was separated and extracted with 50% EtOAc/Hex (3x20 mL). The 
combined organic layers were dried over MgSO4, filtered, and concentrated. Purification 
was accomplished by silica gel flash column chromatography (5-20% EtOAc/Hex) 
affording ketone as a mixture of C22 diastereomers (354 mg, 3.7:1 dr, 92% combined 
yield). This material was used without further purification, and the separation of 
diastereomers was performed at a later stage. TLC Rf = 0.36 (30% EtOAc/Hex); IR (thin 
film) 3436 (bs), 2929, 2864, 2094, 1705, 1355, 1259, 1023, 1002, 906 cm-1; 1H NMR 
(500 MHz, CDCl3) δ (major diastereomer) 6.53 – 6.43 (m, 1H, C25H), 6.23 (t, J = 11.1 
Hz, 1H, C24H), 5.31 (t, J = 11.4 Hz, 1H, C23H), 5.27 – 5.22 (m, 1H, C26Ha), 5.14 (d, J = 
10.3 Hz, 1H, C26Hb), 3.82 (t, J = 5.5 Hz, 1H, C21H), 3.23 (t, J = 7.0 Hz, 2H, α-N3), 2.65 
(m, 2H), 2.15 (s, 3H, C18H3), 2.13 – 2.00 (bs, 1H, OH), 1.64 – 1.51 (m, 2H), 1.51 – 1.44 
(m, 1H), 1.43 – 1.23 (m, 3H), 1.17 (d, J = 7.2 Hz, 3H, C22CH3);13C NMR (126 MHz, 
CDCl3) δ (major diastereomer 212.6, 132.7, 132.1, 131.9, 119.0, 74.3, 51.4, 49.8, 41.2, 
31.5, 29.3, 29.0, 24.5, 11.6; HRMS: Exact mass calcd for C14H24O2N3 [M+H]+: 
266.1869; found 266.1861 (FAB+). 
 
 
To a cooled (-78 °C) solution of keto-alcohol (180 mg, 3.7:1 dr, 0.68 mmol, 1 equiv) in 
CH2Cl2 (6.8 mL, 0.1 M) was added 2,6-lutidine (157 µL, 1.36 mmol, 2 equiv) and TES-
OTf (169 µL, 0.75 mmol, 1.1 equiv). After 2h, 1,1-dimethyl hydrazine (3.4 mL) was 
added dropwise, followed by TMS-Cl (95 µL, 0.75 mmol, 1.1 equiv). The reaction 
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quenched at 0 °C with saturated aqueous NaHCO3 (20 mL) and then diluted with 
saturated aqueous NaCl (20 mL). The aqueous layer was separated and extracted with 
EtOAc (3x50 mL). The combined organic layers were dried over MgSO4, filtered, and 
concentrated. Purification was accomplished by silica gel flash column chromatography 
(2-5% EtOAc/Hex) affording hydrazone as a mixture of C22 diastereomers (190 mg, 
3.7:1 dr, 66% combined yield). This material was used without further purification, and 
the separation of diastereomers was performed at a later stage. TLC Rf = 0.52 (20% 
EtOAc/Hex); IR (thin film) 2952, 2094, 1457, 1241, 1057, 1004, 903, 786, 737 cm-1; 1H 
NMR (500 MHz, CDCl3) δ (major diastereomer) 6.51 – 6.41 (m, 1H, C25H), 6.09 (t, J = 
11.1 Hz, 1H, C24H), 5.41 (t, J = 10.7 Hz, 1H, C23H), 5.21 – 5.15 (m, 1H, C26Ha), 5.07 (d, 
J = 10.0 Hz, 1H, C26Hb), 3.90 (dd, J = 9.5, 2.1 Hz, 1H, C21H), 3.23 (td, J = 7.0, 2.1 Hz, 
2H, α-N3), 2.68 – 2.59 (m, 1H, C22H), 2.42 (s, 6H), 2.44 – 2.36 (m, 1H, C20H), 1.82 (s, 
3H), 1.63 – 1.46 (m, 3H), 1.43 – 1.19 (m, 3H), 1.04 (d, J = 7.0 Hz, 3H, C20CH3), 0.99 (t, 
J = 8.0 Hz, 9H, TES), 0.66 (q, J = 8.1 Hz, 6H, TES); 13C NMR (125 MHz, CDCl3) δ 
(major diastereomer) 169.5, 133.0, 132.9, 131.0, 117.5, 77.5, 51.6, 47.0, 46.9, 42.4, 32.1, 
29.1, 25.0, 16.9, 15.8, 7.3, 5.8; HRMS: Exact mass calcd for C22H44ON5Si [M+H]+: 
422.3315; found 422.3305 (FAB+). 
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There are no reviews of the underlying chemistry of Dictyostatin, outside dissertations1–7 
and a review8 of the related molecule Discodermolide. Therefore, this appendix seeks to 
fill in that gap with an analysis of the major decision points and synthesis plans of Dicty-
ostatin. The discussion will be organized by bond disconnection, so the reader can com-
pare how different groups have approached the same problem. 
Dictyostatin contains three stereochemical islands: C6-7, C12-C14, and C19-C22 
(Figure 1). Thus, any intuitive deconstruction will eventually afford three fragments, each 
containing one of the islands. These fragments will herein be referred to as Fragments A, 
B, and C, respectively, i.e. fragment A contains the C6-C7 stereocenters. The major deci-
sions points will be in configuring the fragments such that they can be coupled, in partic-
ular the couplings of (1) fragments A and B and (2) fragments B and C. 





















II: C10-C11 cis-allylic hydroxyl 
In assessing the structural requirements of Dictyostatin, the C10-C11 cis-allylic hydroxyl 
emerges as the most challenging element. Cis-allylic hydroxyls are non-trivial to synthe-
size in isolation, and C10-C11 stands at a juncture between fragments A and B. Thus, the 
allylic hydroxyl must be synthesized in the context of a fragment coupling reaction. 
 
Scheme 1: (A) Dictyostatin's C10-C11 cis-allylic hydroxyl; (B) C11-C12 disconnec-




In a general sense, two complementary strategies have been advanced: (a) C10-C11 dou-
ble bond formation (Schemes 1B and 2); (b) C9-C10 single bond formation (Schemes 1C 
and 3). The challenge of a C10-C11 strategy is that the olefination must be cis-selective, 
while the challenge of a C9-C10 strategy is that the carbon-carbon bond formation must 
concomitantly set the C9 stereocenter. As will be discussed, prior to our group's applica-
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C10-C11 Bond Disconnection (Scheme 2): Two reaction types have been employed to 
set the C10-C11 olefin: (1) metathesis and (2) Z-selective olefination. 
 
1. Metathesis: As metathesis reactions are generally E-selective and the C10-C11 olefin 
is Z-configured, the Curran,9,10 Phillips,11 and Hanson12 groups devised tethers to enable 
the metathesis to occur intramolecularly. These RCMs are highly Z-selective and proceed 
with good yields (57-78%). Further, the functional groups required for RCMs can be ac-
cessed via scalable methods: the "top" synthon in a crotylation reaction and the "bottom" 
synthon via the two strategies outlined in Scheme 4. 
Scheme 4: Synthesis Strategies for RCM Synthons 
 
However, metathesis reactions are incompatible with the other olefin systems in Dicty-
ostatin: the cis-dienoate (C2-C5) and cis-diene (C23-C26). Therefore, these diene func-
tionalities must be incorporated after the RCM, which can result in a non-convergent 
route. Further, because the RCM tether is not in the final molecule, additional deprotec-





















2. Z-Selective Olefination: (A) Wittig and (B) Still-Gennnari 
(A) Curran employed a Wittig reaction in his Discodermolide13 and Dictyostatin14 stud-
ies. The coupling was, for at least one substrate, quite effective (>20:1 Z:E) but evidently, 
an unpredictable element to its success was the formation of a non-hydroscopic phospho-
nium salt. Thus, while the phosphonium salt boxed in Figure 2 performed well, the others 
depicted were ill behaved. 
Figure 2: Phosphonium Salts for Wittig Coupling 
 
 
(B) Paterson employed Still-Gennari reactions, with good (>5:1) Z:E selectivities, in syn-
theses of both Discodermolide15–17 and Dictyostatin.18–20 Thus, applicability was demon-
strated in a variety of coupling settings. 
Subsequently, our group adopted Paterson's precedent and coupled two fragments 
containing the entire carbon backbone of Dictyostatin (C1-C10 and C11-C26). We also 
improved Paterson's reaction conditions with the discovery that THF can be used as sol-
vent instead of the carcinogenic HMPA. Lastly, we developed (1) a more practical syn-
thesis of complex keto-phosphonates (Scheme 3.31) and (2) conditions to reduce the re-
sultant enone with >10:1 selectivity for the desired C9 alcohol (Scheme 3.45). Arguably, 
this Still-Gennari / CBS sequence constitutes the most general solution for the "cis-allylic 




























C9-C10 Bond Disconnection (Scheme 3): The dominant reaction in this regime is the 
metallation of a cis-vinyl iodidea (usually by t-butyl-lithium), followed by addition into 
an aldehyde.21 However, this reaction has invariably suffered from low yields, with poor 
(and questionable22) selectivity for the desired C9 diastereomer. Further, de-iodination is 
a serious problem (up to 30%), owing to premature quenching of the intermediate vinyl 
lithium species. 
More recently, Curran21 and Cossy23 have published couplings using a Nozaki-
Hiyama-Kishi (NHK) reaction, which is known to be less moisture-sensitive.24 However, 
these NHK reactions are oxygen-sensitive and typically require super-stoichiometric (10-
20 eq.) CrCl2. The intermediate vinyl chromium also appears to suffer from low reactivi-
ty, even when the addition occurs intramolecularly, thus necessitating long reaction times 
(up to a week). Lastly, the addition affords a mixture of C9 diastereomers, evidently due 
to poor substrate control. Thus, when evaluated in totality, these iodide metallation strat-
egies are inadequate for delivering high yields and selectivities. 
A 3rd reaction variant has also appeared: Curran coupled an alkyne and amide, fol-
lowed by reduction, in his 1st generation Dictyostatin synthesis.25 Here, the alkyne metal-
lation readily occurs with n-butyl-lithium, and the ynone reduction is highly selective us-
ing Noyori's transfer hydrogenation. However, the alkyne reduction cannot be performed 
in the presence of the cis-dienoate (C2-C5) or cis-diene (C23-C26) systems. Therefore, as 
with the RCM strategy, these functionalities must be introduced after fragment coupling, 
resulting in a rather non-convergent route. 
                                                      


















Part III: Coupling of Fragments B and C 
Beyond the C10-C11 cis-allylic alcohol, the next decision point facing the Dictyostatin 
chemist is how to join fragments B and C (Schemes 5 and 6). Between the lone C16 me-
thyl stereocenter and the C19-C22 stereoquartet are two methylene groups. Because of 
this lack of synthetic handles, a priori it is unclear which bond to disconnect (for exam-
ple, see Scheme 3.22 for our group's failed attempts). The solution is to introduce the ap-
propriate functionality that enables coupling but that can subsequently be removed. 

































































































































































































































































































































































































































2) chiral Ir(I), H
2



































































    Zn(O











































































1. Fragment C as the Nucleophilic Coupling Partner 
By far, the most common solution to joining fragments B and C is to disconnect the C17-
C18 bond (Scheme 5B): a carbon anion is generated at C18 to react with an electrophile 
at C17. To lower the pKa of C18, the C19 alcohol can be oxidized to a carbonyl. In our 
own synthesis, this carbonyl was then converted to a hydrazone for a lithio-enamine al-
kylation. However, the preferred method by others is to convert the carbonyl to a keto-
phosphonateb (further lowering the pKa) for a HWE E-olefination.19 This HWE has the 
substantial practical benefit of being run in THF / H2O. Therefore, the deprotonation is 
obviously insensitive to moisture; compare that to our group's LDA alkylation, which re-
quires strictly anhydrous conditions. 
In either case – alkylation or HWE – the C19 ketone must be reduced after frag-
ment coupling. This has typically been accomplished by relaying the stereochemistry at 
C21 through a directed reduction. Depending on the protecting group of the C21 hydrox-
yl, various hydride agents have been used: Et2B-OMe / NaBH4; LiAlH(OtBu)3; Zn(BH4)2. 
 
2. Fragment B as the Nucleophilic Coupling Partner 
A lesser strategy is to disconnect the C18-C19 bond (Scheme 5C): a carbon anion is gen-
erated at C18 to react with a C19 electrophile. This carbon anion has taken the form of (a) 
a metallated-alkyne (Gennari26,27) or (b) an alkyl-lithium generated from Li-I exchange 
(Maier28). 
  
                                                      




























IV: Remaining Structural Elements 
The remaining elements of Dictyostatin were addressed in the indicated section: 
§ Stereotriads C12-C14 and C20-C22: Chapter 2 
§ C16 lone methyl stereocenter: Scheme 3.7, page 53 
§ cis-dienoate C2-C5: Scheme 3.35, page 76 
§ cis-diene C23-C26: Scheme 3.16, page 60 
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I: Introduction 
Microtubules are 1 of 3 cytoskeletal proteins, the others being intermediate filaments and 
actin (Figure 1). Microtubules play vital roles in cell motility and transport, and as shown 
in Figure 2, are responsible for aligning and separating chromosomes during cell division. 
Small molecules that affect the dynamics of cell division can result in cell death or 
accelerated senescence,1 both of which are recognized mechanisms of tumor suppression. 
Accordingly, microtubules have been called the best cancer target yet identified.2,3 
 
Figure 1: Fluorescence Microscopy of 2 Cells: microtubules (yellow), actin (white) 
 
This appendix is designed to provide background information on microtubules and the 
small molecules that bind them. It will contain 3 parts: (a) a discussion of microtubule 
self-assembly; (b) a discussion of how small molecules perturb the assembly process; and 
(c) a model for Dictyostatin-microtubule binding. 
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II: Microtubule Self-Assembly 
How do microtubule-binding agents affect mitosis? To answer this question, we have to 
consider the process of microtubule self-assembly. Microtubules are dynamic polymers 
of the protein tubulin, which itself is a heterodimer of α and β tubulin. These tubulin units 
polymerize head-to-head to form protofilaments, which in turn associate laterally to 
become the walls of a hollow cylindrical tube (Figure 2). 
During mitosis, microtubules rapidly grow and shrink until they attach to a 
chromosome and begin the process of alignment and separation (Figure A). As there are 
23 chromosomal pairs, this process must be highly synchronized and require fast kinetics. 
If the polymerization dynamics were blocked, slowed, or otherwise affected, the 
chromosomes would be unable to separate. Cell cycle checkpoints would remain unmet 
and mitotic arrest would occur. 
 
 
Figure 2 (Left): Phases of Mitosis: microtubules (green); DNA (blue) 
Figure 2 (Right): Schematic of Microtubule Polymerization / Depolymerization 
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Small molecules can disrupt the polymerization dynamics by (a) binding to unassembled 
tubulin and preventing polymerization or (b) binding to assembled tubulin and preventing 
de-polymerization. The former are referred to as destabilizers and the latter as stabilizers. 
Because Dictyostatin is a member of the latter category, this discussion will be confined 
to microtubule-stabilizing agents or MSAs.a Well-known MSAs are depicted in Figure 3 
and include Taxol, the Epothilones, Discodermolide, and Peloruside. 
 
Figure 3: Microtubule-Stabilizing Agents (year of discovery) 
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III: MSA-Tubulin Binding 
The first high-resolution (sub-4Å) structure of an MSA–tubulin complex was determined 
using Taxol as the MSA and zinc-induced sheets as the assembled form of tubulin (1JFF, 
Figure 4 Left).4,5 No MSA-tubulin structures have been reported using microtubules as 
the assembled form of tubulin.b Subsequently, crystal structures of epothilone bound to 
assembled6 (1TVK) and unassembled7 (4I50, Figure 4 Right) tubulin were disclosed. In 
addition to these solid-state structures, solution structures based on interligand NOE data 
were proposed for discodermolide (2006)8 and epothilone (2007),9 both bound to 
unassembled tubulin. 
 
Figure 4 (Left): Electron Crystallography of assembled tubulin – Taxol (yellow) 
Figure 4 (Right): X-Ray of unassembled tubulin – Epothilone (yellow), GTP (red) 
 
Docking of the Taxol-bound tubulin structure (Figure 4 Left) into a cryo-EM microtubule 
structure revealed the Taxol binding site to be on the inside wall of the microtubule.10,11 
In fact, all MSAs bind to the taxane luminal site except for Peloruside and Laulimalide, 
which are believed to bind to a distinct β-tubulin site.12 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
b The difference between sheets and microtubules relates to the directionality of adjacent protofilaments.11 
In sheets, the protofilaments are in an anti-parallel relationship while in microtubules, they are parallel. 
Therefore, the lateral contacts, as for example manifested in the M Loop, are necessarily different between 
sheets and microtubules. 
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Access to the taxane luminal site was initially proposed to occur by diffusion through 
small openings or pores in the microtubule wall.13 However, it was later found that Taxol 
binding to β-tubulin is diffusion-limited, an observation seemingly incongruent given the 
comparable dimensions of the pore and Taxol (Figure 5A).14 This paradox was resolved 
with the discovery of a second MSA binding site: in the pore itself (Figure 5B).15 Thus, 
the current consensus on MSA-microtubule binding is that the MSA first binds with fast 
kinetics to the pore site (red, H6-H7 Loop) before being internalized to the luminal site 
(blue, M Loop).12 
  
Figure 5:  (a) Dimensions of Taxol vs. Microtubule Pores 
(b) Pore Site: H6-H7 loop (red); Lumen site: M loop (blue) 
 
As seen in Figure 5, assembled tubulin is "straight" (with the tubulin units directly on top 
of each other) whereas unassembled tubulin is "curved" (Figure 4 Right). Thus, at some 
point during the assembly process, tubulin must undergo a conformational change from 
curved to straight. One cannot easily build stable cylindrical tubes if the walls are curved, 
whereas straight walls allow for more extensive lateral contacts. Thus, the more favorable 
this conformational change is, the more likely it is for tubulin to polymerize. 
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Indeed, a leading theory for how MSAs stabilize microtubules relates to the energetics of 
this curved-to-straight conformational change.7 Briefly, in the taxane-binding site, MSAs 
interact with a key loop region (F272-V288) of β-tubulin known as the M Loop, which 
mediates the protein-protein interface between lateral protofilaments (Figure 5B). MSA 
binding re-structures the M Loop from being a relatively disordered entity (invisible in 
the crystal structures) to a well-defined helix (or loop) better able to accommodate the 
curved-to-straight conformational change. The β-β interface is stabilized and in turn, the 
whole of the microtubule structure; de-polymerization is concomitantly blocked. In this 
theory, M loop restructuring is considered the primary mechanism for how MSAs affect 
the mitotic cycle. 
Thus, many groups have attempted to synthesize MSA analogs with increased M 
loop binding affinities.16,17 However, an atomic-resolution model of most MSA binding is 
currently lacking. For example, compare the solution structure of Epothilone proposed 
from NOE experiments9 and the solid-state structures of Epothilone bound to assembled6 
and unassembled7 tubulin. Three distinct models of Epothilone binding are presented in 
these three publications. 
To our knowledge, there has yet to be a single, convincing pharmacophore model 
that can account for all SAR studies, presumably due to (a) structural differences in the M 
Loops of assembled and unassembled tubulin; (b) structural differences in the M Loops 
of the two forms of assembled tubulin (sheets vs. microtubules);11 (c) the presence of the 
intermediate pore binding site. In the following section, two radically different models for 
Dictyostatin binding will be presented. 
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IV: Dictyostatin-Microtubule Binding 
Two competing models for Dictyostatin binding in the taxane site have been advanced, in 
2008 by Dı́az18 and in 2011 by Snyder.19 As shown in Figures 6 and 7, they could not be 
more different, in both relative and absolute conformation. 
 
   
Figure 6: Superposition of the Snyder (gold) and Dı́az (green) DCT Conformations, 
in a relative sense (Left) and in an absolute sense (in β-Tubulin) (Right)19 
 
 
     
Figure 7: Snyder (L) and Dı́az (R) Models for Dictyostatin Binding in β-Tubulin.19 
The absolute orientations of Dictyostatin are rotated 180° from each other. 
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To quantity the likelihood that one of these models represents the actual Dictyostatin 
binding pose, the Snyder team "scored" the two relative conformations using an approach 
called NAMFIS (NMR Analysis of Molecular Flexibility in Solution)c and reported that 
they are of equal quality with respect to the NMR data; i.e. both models can account for 
the experimentally-determined 3JH-H couplings and NOESY cross-peaks. However, with 
respect to their energetic characteristics, i.e. which conformation is lower in energy, the 
Snyder conformation is evidently present in solution (DMSO) as a minor contributor to 
the equilibrium distribution (7%), whereas the Dı́az conformation cannot be found in 
either DMSO or MeOH. Thus, the Snyder conformation is more likely to represent the 
actual binding pose, the logic being that it is unlikely the microtubule can extract a ligand 
conformation not already present, in at least some small extent, in solution. Further, the 
Snyder conformation, when bound in the taxane site, can adopt an absolute pose that is 3 
kcal lower in energyd and can, according to their analysis, account for the published SAR 
studies to a greater degree.e 
IV: Conclusion 
In this appendix, I have sought to explain at a chemical level how MSAs like Dictyostatin 
bind to microtubules, which in turn affect the processes of cell division and cell death. By 
understanding the intimate details of MSA binding, as presented in Figures 6 and 7, one 
is aided in the discovery process toward MSA analogs with superior properties. 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
c NAMFIS is a computational method that scores conformations by comparing experimental and calculated 
NMR values for 3JH-H coupling (dihedral angels) and NOESY cross-peaks (interatomic distances). 
d The force fields used to score the absolute poses do not incorporate explicit water molecules, an important 
and perhaps dominant role in molecular recognition.22,23 The WaterMap method, developed by the Friesner 
Group to capture the location and thermodynamics of water molecules, has not been applied to microtubule 
binding ligands, to the best of our knowledge. 
e Two important SAR modifications: (1) C2-C6 diene saturation; (2) C16-Me depletion 
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 (contaminated with phosphine impurities) 
 



























































































































































































































































































































































































































NMR from Chapter 4 
 
 
1H NMR (500 MHz, CDCl3) 




















13C NMR (125 MHz, CDCl3) 
mixture of C6 diastereomers (2.5:1 dr)  
  
	  























































































































































































































1H NMR (500 MHz, CDCl3) 




















13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 


















13C NMR (125 MHz, CDCl3) 
mixture of C22 diastereomers 
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